https://www.dailyhealthindustry.it/ecco-come-sara-laifa-del-futuro-accesso-e-rimborso-alle-terapie-avanzate-subito-dopo-lapprovazione-ema-piattaforma-online-per-la-comunicazione-con-le-aziende-del-farmaco-e-meno-bur/ 2024-05-17T09:39:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-acquisisce-proteologix-per-rafforzare-il-portafoglio-degli-anticorpi-bispecifici/ 2024-05-17T10:13:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-45-milioni-di-sterline-per-combattere-la-resistenza-antimicrobica-nei-paesi-piu-colpiti/ 2024-05-17T10:37:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-global-operations-matthew-shields-nuovo-executive-vp/ 2024-05-17T12:23:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/q1-2024-lilly-e-novo-nordisk-guidano-la-classifica-della-crescita-dei-ricavi/ 2024-05-17T14:29:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-nuove-soluzioni-che-sfruttano-lai-per-cambiare-la-diagnostica-per-immagini/ 2024-05-20T09:23:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-vende-la-sua-partecipazione-in-haleon-per-oltre-un-miliardo-di-sterline/ 2024-05-20T14:08:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-avanzate-entro-il-2030-fino-a-60-nuovi-farmaci/ 2024-05-20T12:15:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biopharma-ma-in-forte-ripresa-nei-primi-mesi-del-2024/ 2024-05-20T14:05:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-con-la-piattaforma-tavi-evolut-maggiore-qualita-di-vita-per-le-donne-con-stenosi-aortica-severa/ 2024-05-20T14:51:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-italy-sceglie-elisa-martelli-per-guidare-il-market-access/ 2024-05-21T09:12:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-scommette-sulla-produzione-di-adc-15-miliardi-di-dollari-per-un-impianto-a-singapore/ 2024-05-21T09:42:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-e-astrazeneca-estensione-di-uso-per-tezepelumab-nella-bpco/ 2024-05-21T10:30:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-gruppo-medicair-acquisisce-adi-gruppo-sanimedica/ 2024-05-21T10:48:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assosalute-federchimica-michele-albero-eletto-presidente/ 2024-05-21T15:05:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/agenzie-regolatorie-oms-approva-la-designazione-di-33-enti-nazionali-e-regionali-come-who-listed-authorities/ 2024-05-21T14:49:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-ema-pubblica-nuove-linee-guida-per-lindustria-e-gli-organismi-accreditati/ 2024-05-22T08:07:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almaviva-e-ascom-insieme-per-la-sanita-digitale/ 2024-05-22T08:37:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-ce-via-libera-a-iptacopan-nella-epn/ 2024-05-22T09:41:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-cresce-la-spesa-privata-mentre-il-ricorso-agli-equivalenti-e-ancora-basso-soprattutto-al-sud/ 2024-05-22T11:04:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-vasto-incendio-in-corso-negli-uffici-di-copenaghen/ 2024-05-22T16:33:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-dati-a-4-anni-confermano-efficacia-e-sicurezza-di-deucravacitinib-nella-psoriasi/ 2024-05-22T12:59:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-ed-esperion-therapeutics-ce-approva-acido-bempedoico-e-la-sua-associazione-a-dose-fissa-con-ezetimibe-per-colesterolemia-e-rischio-cardiovascolare/ 2024-05-22T14:54:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-il-regime-di-combinazione-con-acalabrutinib-migliora-la-pfs-nel-linfoma-a-cellule-mantellari/ 2024-05-23T09:21:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-da-ue-ok-a-due-biosimilari-di-denosumab/ 2024-05-23T14:12:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-acquisisce-human-immunology-biosciences-per-115-miliardi-di-dollari-e-si-espande-nellimmunologia/ 2024-05-23T15:05:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lillly-ancora-una-mossa-nel-settore-dei-radiofarmaci-partnership-con-aktis-oncology/ 2024-05-23T16:48:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/caso-triptorelina-aifa-incontra-le-societa-scientifiche/ 2024-05-23T15:45:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-altri-53-miliardi-di-dollari-per-potenziare-la-produzione-di-mounjaro-e-zepbound/ 2024-05-27T09:38:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-ok-aifa-a-rimborsabilita-opzelura-nella-vitiligine/ 2024-05-27T10:10:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-da-think-tank-europeo-tre-raccomandazioni-per-un-approccio-olistico-alle-cure-cardiovascolari/ 2024-05-27T15:58:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-guselkumab-efficace-e-sicuro-nella-colite-ulcerosa-e-nella-malattia-di-crohn/ 2024-05-27T13:22:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-per-dupilumab-ottimi-risultati-nella-bpco-non-controllata/ 2024-05-27T14:19:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/efpia-ogni-anno-in-piu-di-data-protection-costerebbe-allue-123-miliardi-nulla-in-confronto-a-riduzione-investimenti-e-accesso-a-cure/ 2024-05-28T08:43:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-allasco-i-risultati-di-due-studi-sulladc-sacituzumab-tirumotecan/ 2024-05-28T13:12:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ok-ce-a-awiqli-insulina-a-somministrazione-settimanale/ 2024-05-28T14:10:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-italia-progetto-mi-vedete-per-una-cultura-della-salute-mentale-tra-i-giovani/ 2024-05-28T14:37:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-successo-di-semaglutide-nella-patologia-renale/ 2024-05-29T06:34:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-simm-e-periplo-arriva-smart-care-best-setting-model-per-dare-concretezza-ai-principi-del-pnrr-e-del-dm-772022/ 2024-05-29T09:05:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-con-dato-dxd-migliora-la-sopravvivenza-libera-da-progressione-nei-pazienti-con-nsclc-localmente-avanzato-o-metastatico/ 2024-05-29T10:35:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-acquisisce-yellow-jersey-therapeutics/ 2024-05-29T12:43:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-aumentano-del-46-i-finanziamenti-venture-capital/ 2024-05-29T13:27:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parte-pronto-diabete-campagna-nazionale-sul-diabete-di-tipo-2-con-la-partnership-di-astrazeneca/ 2024-05-29T14:09:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-da-fda-revisione-prioritaria-per-inavolisib-cancro-della-mammella/ 2024-05-30T15:34:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/due-nuovi-biosimilari-approvati-nella-ue-e-negli-usa/ 2024-05-30T09:43:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-acido-bempedoico-riduce-il-rischio-di-eventi-cv-in-vari-sottogruppi-di-pazienti/ 2024-05-30T14:45:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-incursione-nelloculistica-acquisita-la-biotech-eyebio/ 2024-05-30T13:47:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/landazabal-gsk-in-italia-investimenti-per-800-milioni-di-euro-nel-2020-2025/ 2024-05-30T15:38:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-protagonista-allascola-combinazione-regn7075-cemiplimab-efficace-nel-carcinoma-colorettale-stabile-ai-microsatelliti/ 2024-05-31T15:42:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-asco-a-5-anni-di-follow-up-lorviqua-aumenta-la-sopravvivenza-nel-nsclc-alk-in-stadio-avanzato/ 2024-05-31T15:33:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-menarini-lucia-aleotti-nominata-cavaliere-del-lavoro/ 2024-05-31T14:20:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-asco-per-osimertinib-e-durvalumab-ottimi-risultati-negli-studi-laura-e-adriatic-sul-tumore-del-polmone/ 2024-06-03T09:16:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-trastuzumab-deruxtecan-cambia-lo-standard-di-cura-nel-tumore-della-mammella-metastatico/ 2024-06-03T10:55:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-chmp-dellema-raccomanda-lapprovazione-in-ue-di-dupilumab-per-i-pazienti-con-bpco/ 2024-06-03T13:06:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assemblea-oms-ok-a-pacchetto-emendamenti-al-regolamento-sanitario-internazionale-entro-un-anno-via-a-piano-pandemico-globale/ 2024-06-03T13:43:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-la-fda-approva-il-vaccino-anti-rsv/ 2024-06-04T09:33:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fidia-accordo-con-sanofi-per-lacquisizione-di-medicinali-ginecologici/ 2024-06-04T10:10:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-aifa-pubblica-aggiornamento-determina-su-procedura-del-silenzioassenso-alle-variazioni-di-autorizzazioni-di-tipo-i/ 2024-06-04T10:09:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-per-i-bambini-aumenta-uso-di-antibiotici-e-cortisonici-i-dati-pdf-98-milioni-di-confezioni-vendute/ 2024-06-05T07:11:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-melissa-seymour-nuova-evp-of-global-quality/ 2024-06-05T08:49:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-bene-studio-di-fase-iii-sullantidepressivo-seltorexant/ 2024-06-05T10:04:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-un-tram-per-sensibilizzare-sullepatite-c/ 2024-06-05T12:48:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-asco-con-asciminib-efficacia-maggiore-nella-leucemia-mieloide-cronica-di-nuova-diagnosi/ 2024-06-05T14:05:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-dellambiente-cattani-farmindustria-imprese-in-prima-linea-per-difenderlo-negli-ultimi-10-anni-consumi-energetici-complessivi-ridotti-del-32/ 2024-06-05T15:30:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-studio-rwe-exacoscv-la-bpco-aumenta-il-rischio-di-eventi-cardiovascolari-dopo-una-riacutizzazione/ 2024-06-06T09:46:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-in-rapida-crescita-il-mercato-delle-small-molecule-iniettabili/ 2024-06-06T12:22:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/elezioni-europee-appello-del-patient-think-tank-mettere-la-salute-al-centro/ 2024-06-06T12:44:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-ottimi-risultati-per-seladelpar-pbc-in-vista-della-decisione-fda/ 2024-06-06T13:25:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-tavolo-tecnico-per-revisione-delle-note-aifa-e-dei-piani-terapeutici/ 2024-06-06T14:56:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-sceglie-josep-catlla-come-chief-corporate-affairs-officer/ 2024-06-07T09:04:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-investe-nei-farmaci-a-base-di-acidi-nucleici-e-acquisisce-elsie-biotechnologies/ 2024-06-07T12:49:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-adagrasib-aumenta-la-sopravvivenza-nel-nsclc-avanzato-o-metastatico-con-mutazione-kras/ 2024-06-07T10:36:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-accordo-con-quralis-per-candidato-sla/ 2024-06-07T12:45:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ce-approva-alectinib-monoterapia-nel-nsclc-alk-positivo-in-stadio-iniziale/ 2024-06-10T09:35:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-dallasco-lo-stato-dellarte-di-nivolumab-nel-nsclc-di-stadio-precoce-e-avanzato/ 2024-06-10T12:32:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-dati-positivi-per-il-vaccino-combinato-influenzacovid/ 2024-06-10T14:00:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-il-primo-inibitore-della-telomerasi-per-le-sindromi-mielodisplastiche/ 2024-06-10T13:59:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-estende-partnership-con-marengo-accordo-da-12-miliardi-di-dollari-per-la-ricerca-sulle-cellule-t/ 2024-06-11T09:27:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-comitato-consultivo-fda-dice-si-a-donanemab-alzheimer/ 2024-06-11T09:25:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-vifor-rimborsabilita-per-avacopan-nelle-vasculiti-anca-associate/ 2024-06-11T13:53:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicines-for-europe-una-legge-sui-farmaci-critici-nei-primi-100-giorni-del-nuovo-parlamento-ue/ 2024-06-11T12:05:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seqirus-contratto-quadro-con-hera-per-vaccino-prepandemico-influenza-aviaria-in-europa/ 2024-06-11T16:12:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-dopo-unintensa-attivita-di-ma-arriva-un-periodo-di-riposo/ 2024-06-12T08:47:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/efpia-un-pentalogo-per-raggiungere-la-sostenibilita-ambientale/ 2024-06-12T09:47:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-crea-gruppo-di-lavoro-per-migliorare-laccesso-agli-antibiotici/ 2024-06-12T10:24:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-momento-doro-degli-adc/ 2024-06-12T12:26:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-accordo-tra-biotech-italiana-e-md-anderson-per-scoperta-e-sviluppo-fid/ 2024-06-12T13:02:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boerner-ceo-bms-vogliamo-ancora-investire-in-ma/ 2024-06-13T10:03:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-kyriakides-con-riforma-legislazione-ue-nuovi-medicinali-raggiungeranno-70-mln-di-pazienti-in-piu-e-industria-risparmiera-tra-500-milioni-e-1-miliardo-di-euro-in-15-anni/ 2024-06-13T10:37:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accordo-flagship-profound-su-candidati-anti-obesita-per-pfizer/ 2024-06-13T13:04:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-band-aid-e-il-brand-pharma-preferito-dalla-generazione-z/ 2024-06-13T13:48:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cirrosi-epatica-i-pazienti-chiedono-meno-burocrazia-e-maggior-accesso-al-teleconsulto/ 2024-06-14T08:39:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-group-e-synlab-italia-partecipano-allinnostars-connect/ 2024-06-14T12:05:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-medicine-rafforza-il-proprio-impegno-in-italia-580-mln-di-euro-nei-prossimi-cinque-anni/ 2024-06-14T15:28:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-entro-il-2030-otto-blockbuster-antitumorali/ 2024-06-14T15:07:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-opzione-per-farmaco-biotech-cinese-per-la-leucemia-mieloide-cronica/ 2024-06-17T09:09:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-inebilizumab-raggiunge-lobiettivo-primario-in-studio-sulla-malattia-da-immunoglobulina-g4/ 2024-06-17T09:49:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-nasce-il-progetto-pmlab-per-i-pazienti-covid19-imunocompromessi/ 2024-06-17T12:59:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-accordo-con-biotech-cinese-per-anticorpo-nella-terapia-delle-ibd/ 2024-06-17T15:19:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fair-play-menarini-assegnato-il-premio-speciale-fiamme-gialle-studio-e-sport/ 2024-06-17T16:06:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/italfarmaco-collaborazione-con-iktos-per-lutilizzo-dellai-nellindividuazione-degli-inibitori-hdac/ 2024-06-18T09:08:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-con-lo-screening-polmonare-aumenta-la-sopravvivenza-di-oltre-7-anni-e-si-risparmiano-2-3-miliardi-di-euro/ 2024-06-18T09:53:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/efpia-persistono-disparita-nei-tempi-di-accesso-ai-farmaci-media-ue-531-giorni/ 2024-06-18T12:23:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-fda-approva-primo-vaccino-contro-lo-pneumococco-destinato-agli-adulti/ 2024-06-18T12:31:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-partnership-da-700-milioni-con-biotech-usa-per-candidati-small-molecule/ 2024-06-19T09:25:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-fda-approva-keytruda-nel-tumore-dellendometrio/ 2024-06-19T10:03:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/istituto-pascale-progetto-hvas-un-operatore-sanitario-guida-in-teleassistenza-i-caregiver-dei-pazienti-oncologici/ 2024-06-19T11:44:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-in-oncologia-35-nuove-richieste-di-autorizzazione-di-farmaci-entro-il-2030/ 2024-06-19T13:26:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-gilad-le-ultime-novita-dal-congresso-eha-2024/ 2024-06-19T15:27:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-terzo-incendio-nel-giro-di-un-mese/ 2024-06-20T08:56:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-accordo-con-la-biotech-ascidian-per-farmaci-rna-exon-editing/ 2024-06-20T09:32:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/elias-khalil-nuovo-presidente-e-amministratore-delegato-italy-hub-di-lilly/ 2024-06-20T09:54:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-ok-ue-per-altuvoct-terapia-a-lunga-durata-dazione-per-lemofilia-a/ 2024-06-20T10:27:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-focus-su-dialogo-paziente-medico-con-liniziativa-hiv-parliamone-ancora/ 2024-06-20T13:11:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-del-rifugiato-a-pfizer-il-premio-dellunhcr/ 2024-06-20T15:36:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-biologics-accordo-con-baxter-per-produzione-a-contratto-fino-al-2034/ 2024-06-21T07:26:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-nuova-strada-per-skyrizi-nelle-ibd-con-lapprovazione-fda-per-la-colite-ulcerosa/ 2024-06-21T09:44:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-risultati-positivi-per-acalabrutinib-al-congresso-eha/ 2024-06-21T12:28:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-kyriakides-ue-non-tutti-i-pazienti-europei-hanno-pari-accesso-a-quelli-innovativi/ 2024-06-21T12:58:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-marchio-ce-per-software-di-programmazione-guidata-dalle-immagini-nella-dbs/ 2024-06-25T14:35:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibsa-italy-crescita-a-doppia-cifra-anche-nel-2023/ 2024-06-25T08:43:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-ok-ce-a-fruquintinib-nel-mcrc-precedentemente-trattato/ 2024-06-25T09:06:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-2024-ecco-i-vincitori-della-sesta-edizione/ 2024-07-11T12:59:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-novavax-presenta-allema-domanda-autorizzazione-del-vaccino-aggiornato-alle-nuove-varianti/ 2024-06-26T12:25:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-un-nuovo-impianto-per-produrre-ozempic-e-wegovy/ 2024-06-25T13:18:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-ce-a-ocrelizumab-sottocute-nella-smr-e-nella-smpp/ 2024-06-26T09:00:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-da-aifa-semaforo-verde-per-le-terapie-car-t-idecel-e-lisocel/ 2024-06-26T10:17:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-inaugurato-il-nuovo-headquarter-a-milano/ 2024-06-27T06:06:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-italia-alfredo-galletti-nuovo-general-manager-dal-1-luglio/ 2024-06-26T12:51:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-sotorasib-ammesso-alla-rimborsabilita-in-italia-nel-nsclc-con-mutazione-kras-pg12c/ 2024-06-26T14:28:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ce-approva-combo-capivasertib-piu-fulvestrant-nel-tumore-al-seno/ 2024-06-27T09:15:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmacentro-stefano-golinelli-confermato-alla-presidenza/ 2024-06-27T10:10:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-efpia-chiede-ufficio-dedicato-alle-scienze-della-vita-allinterno-della-commissione-europea/ 2024-06-27T11:53:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/donne-con-sindrome-dellovaio-policistico-se-la-risposta-fosse-la-semaglutide/ 2024-06-27T13:00:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-amplia-le-sue-prospettive-per-le-ibd-con-lacquisizione-di-celsius/ 2024-06-28T08:32:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-da-2seventy-bio-un-candidato-per-lemofilia-a/ 2024-06-28T08:53:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-partnership-con-openai-per-nuovi-antimicrobici/ 2024-06-28T12:38:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenza-farmaci-aifa-aggiorna-elenco-dei-medicinali-che-non-possono-essere-sottratti-alla-distribuzione-e-alla-vendita/ 2024-06-28T12:53:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valneva-ce-approva-vaccino-contro-la-chikungunya/ 2024-06-28T14:29:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-da-cmp-dellema-ok-a-vaccino-mrna-per-lrsv-negli-over-60/ 2024-06-28T16:08:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/i-farmaci-piu-gettonati-destate-record-antimicotici-antibatterici-e-cortisonici-con-75-mln-di-confezioni-vendute-fra-giugno-e-agosto/ 2024-07-01T08:57:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-la-responsabilita-dei-farmaci-oncologici-a-tina-deignan-ex-novartis/ 2024-07-01T09:11:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-aifa-arriva-nuovo-servizio-di-consultazione-della-banca-dati/ 2024-07-01T12:02:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obesita-dalla-cina-un-candidato-promettente/ 2024-07-01T12:35:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-due-nuove-nomine-ai-vertici-aziendali/ 2024-07-01T15:18:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gedeon-richter-due-nuove-acquisizioni-strategiche-nella-womens-healthcare/ 2024-07-01T15:41:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-kedrion-la-distribuzione-dellimmunoglobulina-ymmugo-biotest-negli-stati-uniti/ 2024-07-02T09:06:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nuovo-accordo-nei-radiofarmaci/ 2024-07-02T09:34:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-nuovo-ingresso-nel-cda/ 2024-07-02T14:28:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-negli-usa-parte-sperimentazione-vaccino-nasale-contro-varianti-emergenti-di-sarscov2/ 2024-07-02T12:17:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-chmp-dellema-raccomanda-comirnaty-adattato-alla-variante-jn1/ 2024-07-02T12:42:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-fda-approva-donanemab-per-la-malattia-di-alzheimer-sintomatica-e-precoce/ 2024-07-03T14:32:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-e-bristol-myers-squibb-stop-allaccordo-per-sviluppo-adc/ 2024-07-03T09:43:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-nuove-linee-guida-sugli-studi-clinici-maggiore-attenzione-alle-minoranze/ 2024-07-03T12:55:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-contraffatti-sei-annunci-online-illeciti-su-10-non-vengono-riconosciuti-dai-consumatori/ 2024-07-03T14:16:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-cattani-confermato-alla-presidenza-per-il-biennio-2024-2026/ 2024-07-03T15:55:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-da-ema-valutazione-accelerata-per-sipavibart-come-profilassi-pre-esposizione-al-covid/ 2024-07-04T07:48:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-e-curevac-nuovo-accordo-di-licenza-sui-vaccini-a-mrna/ 2024-07-04T08:21:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-ema-a-dupilumab-nella-bpco/ 2024-07-04T09:02:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assemblea-di-farmindustria-cattani-record-export-italiano-vale-49-mld-di-euro-nel-2023-ma-serve-nuova-governance-e-superare-payback-va-rivista-anche-la-proposta-di-legislazione-ue/ 2024-07-04T15:39:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/disabilita-vacanze-in-sicurezza-nella-spiaggia-dei-valori/ 2024-07-04T12:31:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-governo-usa-finanzia-lo-sviluppo-di-un-vaccino-contro-laviaria/ 2024-07-05T08:29:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-internazionale-fair-play-menarini-celebrate-correttezza-e-sportivita-in-gara-e-nella-vita/ 2024-07-05T08:52:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/porpora-trombotica-trombocitopenica-anptt-onlus-celebra-la-iii-giornata-nazionale/ 2024-07-05T09:48:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-nuove-nomine-in-dipartimenti-chiave/ 2024-07-05T10:26:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-chiude-le-cessioni-degli-asset-non-strategici-con-un-accordo-sugli-otc/ 2024-07-05T12:47:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intervista-a-confalone-novartis-meno-burocrazia-iter-regolatorio-accelerato-approvvigionamenti-sicuri-e-investimenti-strategici-per-difendere-il-futuro-delleuropa/ 2024-07-08T07:56:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giovanni-filippini-e-il-nuovo-dg-salute-animale-del-ministero/ 2024-07-08T08:49:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-lesperienza-al-centro-una-campagna-di-sensibilizzazione-sulla-malattia-psoriasica/ 2024-07-08T09:31:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/paivi-kerkola-pfizer-e-la-nuova-presidente-di-iapg/ 2024-07-08T09:54:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-un-diario-del-bebe-per-i-neogenitori/ 2024-07-08T12:24:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharma-e-philogen-ema-accetta-mma-per-nidlegy-melanoma/ 2024-07-08T14:27:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-la-banca-dati-dei-farmaci-si-rinnova-per-essere-piu-vicina-ai-cittadini-anche-tramite-lapp/ 2024-07-08T14:46:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/connected-health-nelle-life-sciences-un-motore-per-il-fatturato-nei-prossimi-cinque-anni/ 2024-07-09T08:47:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obesita-nasce-il-nuovo-medical-magazine-edito-da-sics/ 2024-07-05T12:04:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/portare-linnovazione-nella-formazione-in-medicina-lo-studio-di-altems-alla-johnson-johnson-week/ 2024-07-09T09:10:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/continua-a-volare-la-spesa-farmaceutica-nel-2023-sfiora-i-22-miliardi-i-dati-provvisori-aifa/ 2024-07-09T09:28:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-acquisisce-morphic-therapeutics-per-oltre-3-mld-di-dollari/ 2024-07-09T09:56:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grifols-cessione-e-delisting/ 2024-07-09T12:32:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-europa-lancia-una-nuova-rete-per-promuovere-dati-e-soluzioni-digitali-per-la-salute/ 2024-07-10T08:52:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zentiva-italia-accordo-con-sanofi-per-la-vendita-di-prilace/ 2024-07-10T09:10:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/evotec-e-sandoz-ampliano-il-patto-di-produzione-di-biosimilari/ 2024-07-10T09:39:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-il-19-luglio-tavolo-tecnico-per-la-revisione-delle-note-e-dei-piani-terapeutici/ 2024-07-10T10:43:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-week-verso-il-futuro-tra-innovazione-ricerca-e-collaborazioni-strategiche/ 2024-07-10T13:22:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beckman-coulter-arriva-dxc-500i-clinical-analyzer-il-nuovo-analizzatore-integrato-per-dosaggi-di-chimica-clinica-e-immunometria/ 2024-07-11T08:37:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-nuova-centrale-a-biomasse-nel-quartier-generale/ 2024-07-11T09:34:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amylyx-con-avexitide-entra-nellarena-dei-farmaci-glp1/ 2024-07-11T12:42:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-lhealthcare-consumer-unit-nel-mirino-delle-private-equity/ 2024-07-11T12:48:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-limpegno-nella-cura-dellamiloidosi-cardiaca-da-transtiretina/ 2024-07-11T15:14:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-futuro-dei-percorsi-di-cura-tra-innovazione-e-collaborazione-pubblico-privato/ 2024-07-12T07:08:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-acquisisce-yellow-jersey-therapeutics-e-rafforza-la-pipeline-della-dermatite-atopica/ 2024-07-12T09:06:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-un-candidato-per-entrare-nel-mercato-dellobesita/ 2024-07-14T14:34:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-come-conservare-e-utilizzare-i-medicinali-con-il-caldo/ 2024-07-12T10:17:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenza-farmaci-cresce-in-europa-la-preoccupazione-per-leccessiva-dipendenza-da-fornitori-di-principi-attivi-extra-ue-la-relazione-hera/ 2024-07-12T11:54:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-roopal-thakkar-nuovo-chief-scientific-officer/ 2024-07-12T12:42:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-arriva-in-italia-il-sensore-freestyle-libre-2-plus-per-il-diabete/ 2024-07-15T08:42:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-la-sanita-vista-dai-giovani-italiani/ 2024-07-15T11:00:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-completa-lacquisizione-di-eyebio/ 2024-07-15T13:05:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/entra-in-vigore-lai-act-europeo-quali-le-conseguenze-per-la-ricerca-clinica/ 2024-07-15T14:23:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-verso-una-nuova-indicazione-per-upadacitinib-rinvoq/ 2024-07-16T08:09:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-al-via-la-seconda-edizione-del-think-tank-ithaca-le-5-proposte-di-soluzione-ai-nodi-da-sciogliere-nel-settore/ 2024-07-16T08:27:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/morgan-stanley-brevetti-in-scadenza-e-tempo-di-ma/ 2024-07-16T09:12:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diasorin-ok-de-novo-da-fda-per-il-kit-molecolare-simplexa-c-auris/ 2024-07-16T09:47:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diversita-equita-e-inclusione-sanofi-riceve-la-certificazione-uni-iso-304152021/ 2024-07-16T12:17:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cdmo-tedesca-stanzia-900-mln-di-euro-per-espandere-la-produzione-di-glp-1/ 2024-07-17T08:42:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-guida-un-finanziamento-di-100-mln-di-dollari-per-asceneuron-alzheimer/ 2024-07-17T14:22:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-partnerhsip-con-orum-per-farmaci-condizionanti-alla-terapia-genetica/ 2024-07-17T14:13:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-studio-dreamm-7-ottimo-risultato-per-belantamab-mafodotin-gsk-in-combinazione-con-bortezomib-e-desametasone/ 2024-07-17T12:38:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-approvati-5-nuovi-farmaci-tra-cui-due-antitumorali/ 2024-07-17T14:33:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmacopea-europea-dal-2025-mai-piu-test-di-pirogenicita-sui-conigli/ 2024-07-18T09:01:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-investe-in-india-400-milioni-di-euro-per-trasformare-il-sito-di-hyderabad-nellhub-mondiale/ 2024-07-18T09:25:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-italia-a-fianco-di-fondazione-aiom-nella-campagna-tumori-scegli-la-prevenzione/ 2024-07-18T10:17:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-buoni-risultati-dalla-pipeline-glp-1/ 2024-07-18T12:33:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-q2-ottimo-e-aumenta-la-guidance-sugli-utili-2024/ 2024-07-19T07:48:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-q2-allinsegna-dei-dispositivi-medici/ 2024-07-19T08:21:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-loms-aggiorna-le-linee-guida-sui-test-piu-supporto-per-lautotest-lintegrazione-e-la-prevenzione/ 2024-07-19T09:13:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-in-studio-fase-iii-darolutamide-carcinoma-prostata-metastatico-ormonosensibile-raggiunge-endpoint-di-sopravvivenza-libera-da-progressione-radiologica/ 2024-07-20T14:59:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/von-der-leyen-una-strategia-per-le-lifescience-nelleuropa-2024-2029/ 2024-07-22T09:56:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-lancia-negli-usa-biosimilare-di-humira-abbvie-con-il-92-di-sconto/ 2024-07-22T10:28:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nice-approva-il-primo-farmaco-per-il-cancro-alla-prostata-da-assumere-a-casa/ 2024-07-22T12:40:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-aggiorna-le-linee-guida-per-migliorare-laccesso-alla-profilassi-post-esposizione-allhiv/ 2024-07-22T13:07:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-nel-2023-ha-toccato-quota-217-miliardi/ 2024-07-23T09:04:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sifo-arturo-cavaliere-riconfermato-alla-presidenza/ 2024-08-22T08:12:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-indagine-demoscopica-in-italia-epatiti-virali-queste-sconosciute-torna-la-campagna-di-sensibilizzazione-epatite-c-mettiamoci-un-punto/ 2024-07-23T10:12:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-governance-integrata-per-una-crescita-sostenibile/ 2024-07-23T12:48:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grunenthal-acquisisce-valinor-pharma-per-250-milioni-di-dollari/ 2024-07-23T13:27:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/agilent-acquisisce-la-cdmo-biovectra-per-925-milioni-di-dollari/ 2024-07-24T08:51:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/startup-biotech-raccoglie-165-mln-di-dollari-per-sviluppare-anticorpi-multifunzionali/ 2024-07-24T14:41:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-novartis-e-roche-sclerosi-multipla-un-docufilm-per-raccontarla/ 2024-07-24T15:32:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-hiv-regime-a-due-farmaci-dtg3tc-e-efficace-come-quello-a-tre-farmaci-bicftctaf/ 2024-07-24T12:28:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-nuovo-cmo-e-susan-rienow/ 2024-07-25T08:41:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-testacollo-da-fda-designazione-fast-track-a-ozuriftamab-vedotin-di-bioatla/ 2024-07-25T09:05:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beigene-nuovo-stabilimento-hub-negli-usa/ 2024-07-25T09:50:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-buoni-risultati-dalla-terapia-genica-sperimentale-per-lemofilia-a/ 2024-07-25T12:52:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-lancia-il-biosimilare-di-ustekinumab-in-europa/ 2024-07-26T08:59:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-acquisisce-farmaco-per-glioma-pediatrico/ 2024-07-26T09:18:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-alza-le-stime-sugli-utili-per-lintero-anno-dopo-la-crescita-delle-vendite-nel-q2/ 2024-07-26T09:53:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chmp-a-luglio-raccomandati-14-nuovi-medicinali-e-11-estensioni-di-indicazione-disco-rosso-per-leqembi/ 2024-07-26T13:41:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharma-ok-fda-a-leqselvi-per-il-trattamento-dellalopecia-areata-grave/ 2024-07-29T08:22:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pierre-fabre-laboratories-parere-positivo-chmp-per-encorafenib-e-binimetinib-nel-nsclc-avanzato-con-mutazione-brafv600e/ 2024-07-29T09:07:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-e-mario-negri-collaborazione-per-nuovi-target-molecolari-nella-terapia-dellepilessia/ 2024-07-29T10:00:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-malattie-colestatiche-rare-parere-positivo-chmp-per-elafibranor-e-odevixibat/ 2024-07-29T10:38:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-da-chmp-raccomandazione-per-estendere-il-vaccino-rsv-ad-adulti-50-59-anni/ 2024-07-29T12:38:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-e-flagship-partnership-di-ricerca-per-farmaci-e-vaccini/ 2024-07-30T15:45:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-e-medico-diagnostici-in-vitro-in-gazzetta-ufficiale-le-nuove-norme-dellue/ 2024-07-30T09:10:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mercato-dei-farmaci-in-farmacia-pdf-nel-ii-trimestre-2024-vendute-445-milioni-di-confezioni-25-per-un-valore-di-45-miliardi-di-euro-15/ 2024-07-30T15:45:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-il-q2-si-chiude-con-un-fatturato-di-122-miliardi-di-dollari/ 2024-07-30T09:43:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-autorizza-cnr-di-pisa-a-produrre-radiofarmaco-per-diagnosi-di-tumori-cerebrali/ 2024-07-30T10:23:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-acquisisce-la-startup-nerio-therapeutics/ 2024-07-30T12:41:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-progetto-future-per-il-benessere-e-la-salute-emotiva-dei-giovani/ 2024-07-30T13:42:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nuovo-impianto-per-linsulina-in-germania/ 2024-08-02T07:22:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-il-ceo-chris-viehbacher-e-ottimista-su-leqembi/ 2024-08-02T08:08:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-cresce-del14-il-fatturato-nel-primo-trimestre-dellanno-fiscale-2024/ 2024-08-22T08:10:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-alza-la-guidance-per-il-2024/ 2024-08-02T08:44:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-acquisisce-la-biotech-usa-jnana-therapeutics/ 2024-08-02T09:59:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prevenzione-come-pilastro-per-un-ssn-sostenibile-dibattito-al-meeting-di-rimini/ 2024-08-21T12:05:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-pfizer-e-moderna-ok-fda-a-vaccini-mrna-contro-il-ceppo-kp2/ 2024-08-26T07:56:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-fda-approva-combo-per-nsclc-con-mutazione-egfr/ 2024-08-26T08:45:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-due-nuovi-ingressi-nellexecutive-team/ 2024-08-26T09:31:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-e-versant-ventures-lanciano-la-biotech-borealis/ 2024-08-26T13:35:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-da-ce-via-libera-a-odronextamab-per-il-trattamento-del-linfoma/ 2024-08-28T13:42:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/siemens-healthineers-200-mln-di-euro-per-advanced-accelerator-applications-di-novartis/ 2024-08-27T12:52:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/arriva-in-europa-akantior-prima-terapia-per-la-cheratite-da-acanthamoeba/ 2024-08-27T09:53:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-cambio-al-vertice-delle-hr-kristen-mulholland-sostituisce-peter-fasolo/ 2024-08-27T12:25:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-ce-estende-approvazione-di-amivantamab-nel-nsclc-con-mutazione-egfr/ 2024-08-28T14:50:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-da-commissione-europea-via-libera-a-crovalimab-nella-epn/ 2024-08-28T08:34:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-cede-in-cina-attivita-di-neurologia-e-di-allergologia-per-680-milioni-di-dollari/ 2024-08-28T09:28:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-a-un-ex-dirigente-nike-la-responsabilita-dellai-e-della-gestione-dei-dati/ 2024-08-28T15:47:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-rafforza-la-produzione-farmaci-biologici/ 2024-08-28T15:32:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-stada-forte-crescita-nella-prima-meta-dellanno/ 2024-08-28T14:35:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-partnership-con-lindy-bioscences-per-la-somministrazione-sottocutanea-dei-farmaci-biologici/ 2024-08-29T06:35:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-e-nextrna-therapeutics-alla-scoperta-di-nuove-small-molecule-contro-il-cancro/ 2024-08-29T07:47:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-la-commissione-europea-approva-padcev-per-il-trattamento-del-tumore-uroteliale/ 2024-08-29T08:25:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-la-commissione-europea-estende-vaccino-rsv-a-fascia-5059-anni-a-rischio-aumentato/ 2024-08-29T09:38:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-completato-il-trasferimento-nella-ue-della-marketing-authorisation-di-jyseleca-da-galapagos/ 2024-08-29T14:15:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-cellulari-e-geniche-investimenti-in-caduta-libera/ 2024-09-02T09:44:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regno-unito-alleanza-pubblicoprivato-per-studio-e-produzione-di-nuovi-farmaci/ 2024-08-30T09:22:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/unicef-parte-la-campagna-di-vaccinazione-antipolio-a-gaza/ 2024-08-30T13:23:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pierre-fabre-laboratories-commissione-europea-approva-combinazione-encorafenibbinimetinib-nel-nsclc-avanzato-con-mutazione-braf/ 2024-08-30T14:55:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/esc-2024-malattie-cardiovascolari-disuguaglianze-di-genere-e-mancata-aderenza-terapeutica-impattano-sugli-esiti-clinici-dei-pazienti-limpegno-di-daiichi-sankyo-nel-ridurre-i-gap/ 2024-09-02T09:18:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-secondaria-progressiva-non-recidivante-nuovi-risultati-positivi-per-tolebrutinib/ 2024-09-03T09:29:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/revoca-dellaic-condizionata-acido-obeticolico-per-colangite-biliare-primitiva-la-risposta-di-advanz-pharma/ 2024-09-03T09:31:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovi-dati-di-sopravvivenza-real-world-in-pazienti-con-amiloidosi-cardiaca-da-transtiretina/ 2024-09-03T09:34:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuove-linee-guida-aifa-su-studi-osservazionali-nistico-importante-passo-avanti/ 2024-09-03T11:04:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-marcello-cattani-la-laurea-honoris-causa-in-scienze-economiche/ 2024-09-03T12:50:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thomas-gelin-nominato-direttore-esecutivo-affari-internazionali-di-efpia/ 2024-09-04T08:49:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-la-fda-autorizza-il-vaccino-novavax-aggiornato-per-le-varianti-attualmente-in-circolazione/ 2024-09-04T08:53:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amr-arrivano-le-linee-guida-oms-per-frenare-linquinamento-da-produzione-di-antibiotici/ 2024-09-04T08:55:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipertensione-resistente-allesc-servier-presenta-importanti-progressi-con-quadriterapia-in-unica-pillola/ 2024-09-04T10:20:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/infezioni-fungine-invasive-vera-e-propria-emergenza-di-sanita-pubblica/ 2024-09-04T10:27:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-investe-ancora-nella-radioterapia/ 2024-09-05T08:08:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/advanz-pharma-ottiene-sospensione-temporanea-decisione-della-commissione-europea-sullaic-condizionata-di-ocaliva-in-europa/ 2024-09-05T08:55:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-egpa-guggino-unipa-nuove-terapie-per-patologia-autoimmune-complessa/ 2024-09-05T09:20:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-al-congresso-ectrims-con-ottimi-risultati-per-fenebrutinib-nella-sm-recidivante/ 2024-09-05T12:16:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-laura-vergani-la-unit-global-communication-public-affairs-del-gruppo-chiesi/ 2024-09-05T13:38:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/haleon-davide-fanelli-e-il-nuovo-gm-southern-europe-e-italia/ 2024-09-05T14:36:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-accordo-da-un-miliardo-di-dollari-con-haya-therapeutics-per-lavorare-sugli-lncrna-nellobesita/ 2024-09-06T08:11:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amlo-biosciences-messo-a-punto-un-nuovo-biomarcatore-per-il-melanoma/ 2024-09-06T08:39:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sfruttare-lia-nella-regolamentazione-dei-medicinali-da-ema-linee-guida-su-uso-di-modelli-linguistici-di-grandi-dimensioni/ 2024-09-06T12:05:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gedeon-richter-autorizzata-in-uk-la-prima-terapia-combinata-per-lendometriosi/ 2024-09-06T12:27:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cardiomiopatia-ipertrofica-ostruttiva-sintomatica-positivi-i-dati-di-follow-up-a-lungo-termine-dello-studio-di-fase-3-con-mavacamten/ 2024-09-09T07:41:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/landazabal-gsk-italia-innovazione-e-salute-strettamente-connesse-a-competitivita-ue/ 2024-09-09T07:44:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-ottimi-risultati-da-due-studi-per-linsulina-monosettimanale-efsitora/ 2024-09-09T08:46:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-corsa-ciclistica-per-raccogliere-fondi-per-sostenere-il-progetto-case-ail/ 2024-09-09T08:57:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msddaiichi-sankyo-avviano-studio-di-fase-iii-per-adc-contro-il-cancro-del-polmone/ 2024-09-09T09:19:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-nuovi-dati-favorevoli-su-cenobamato-nellepilessia/ 2024-09-09T10:06:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tirzepatide-eli-lilly-riduce-del-94-il-rischio-di-sviluppare-diabete-di-tipo-2-negli-adulti-con-prediabete-obesita-o-sovrappeso/ 2024-09-09T11:24:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/raka-sinha-nuova-general-manager-di-opella-sanofi-in-italia/ 2024-09-10T08:23:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zambon-italia-una-selezione-di-ricette-per-sconfiggere-la-disfagia-delle-persone-con-sla/ 2024-09-10T09:00:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colangite-biliare-primitiva-associazioni-e-clinici-sfruttare-sospensione-per-tutelare-pazienti/ 2024-09-10T09:40:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obesita-tra-le-pharma-concorrenti-spunta-una-biotech-californiana/ 2024-09-10T09:58:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-draghi-sulla-competitivita-ue-efpia-speriamo-sia-un-catalizzatore-per-guidare-il-cambiamento/ 2024-09-10T12:27:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-i-dati-su-depemokimab-mostrano-una-riduzione-del-54-delle-esacerbazioni-dellasma/ 2024-09-10T15:09:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-emofilia-a-aifa-approva-rimborsabilita-emicizumab-per-la-profilassi-di-routine-degli-episodi-emorragici/ 2024-09-11T08:34:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nuovi-dati-positivi-di-fase-iii-per-dupilumab-nella-bpco/ 2024-09-11T09:29:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-allesmo-in-primo-piano-la-combo-fianlimab-cemiplimab-nel-melanoma-avanzato/ 2024-09-11T12:33:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emicrania-nel-2033-ubrogepant-di-abbvie-dominera-il-mercato/ 2024-09-11T13:17:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-italia-podcast-con-la-voce-di-luca-zingaretti-per-la-campagna-di-informazione-sul-mieloma-multiplo/ 2024-09-13T14:52:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-in-francia-un-sito-di-produzione-per-i-farmaci-del-futuro/ 2024-09-12T07:54:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-accordo-con-genesis-therapeutics-per-sviluppare-small-molecule-con-lai/ 2024-09-13T14:52:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-liraglutide-efficace-nella-perdita-di-peso-dei-bambini-obesi/ 2024-09-12T09:03:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-tre-concerti-allalba-per-celebrare-la-ricerca-nel-mese-dei-tumori-ematologici/ 2024-09-12T14:29:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/per-tenere-testa-a-cina-e-usa-la-farmaceutica-europea-deve-cambiare-passo-ecco-il-piano-draghi/ 2024-09-13T07:29:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bavarian-nordic-aumenta-la-produzione-del-vaccino-mpox/ 2024-09-13T13:49:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-investe-18-miliardi-di-dollari-in-irlanda-per-rafforzare-la-produzione-mondiale/ 2024-09-13T09:05:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zambon-bene-gli-studi-promis-i-e-ii-su-colistimetato-sodico-per-via-inalatoria-nella-ncfb/ 2024-09-13T10:07:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sindrome-di-lynch-fondazione-onda-ets-occorre-un-impegno-condiviso-per-migliorare-i-percorsi-di-prevenzione-diagnosi-e-cura/ 2024-09-13T14:47:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/guido-beccagutti-e-il-nuovo-direttore-generale-di-confindustria-dispositivi-medici/ 2024-09-16T06:52:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-due-partnership-per-sviluppare-terapia-tat-per-tumori-rari/ 2024-09-16T07:25:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-e-obesita-la-cinese-innovent-protagonista-al-congresso-easd-con-due-studi-su-mazdutide/ 2024-09-18T10:21:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-promettente-attivita-clinica-preliminare-per-lanticorpo-coniugato-ds-9606-in-pazienti-con-tumori-solidi-avanzati/ 2024-09-16T11:07:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-ecco-i-vaccini-autorizzati-per-la-campagna-vaccinale/ 2024-09-16T12:32:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-allesmo-dati-positivi-su-trastuzumab-deruxtecan-nel-cancro-seno-e-durvalumab-nel-cancro-alla-vescica/ 2024-09-16T12:39:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-nuova-piattaforma-digitale-per-ottimizzare-la-gestione-dei-fondi-di-farmacovigilanza/ 2024-09-16T14:47:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-lo-studio-purpose-2-ha-dimostrato-unefficacia-del-96-di-lenacapavir-nella-prevenzione-dellinfezione/ 2024-09-17T07:39:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riccardo-chiappani-nuovo-oncology-communication-manager-di-daiichi-sankyo-italia/ 2024-09-17T08:47:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/screening-pediatrico-per-diabete-di-tipo-1-ecco-le-16-nuove-raccomandazioni-per-limplementazione-a-livello-nazionale/ 2024-09-17T10:36:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-programma-di-fase-iii-per-amivantamab-nel-cancro-del-colon-retto/ 2024-09-17T12:34:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-da-checkmate067-risultati-eccellenti-a-lungo-termine-per-la-combo-opdivoyervoy-nel-melanoma/ 2024-09-17T13:58:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ovarian-cancer-committee-garantire-a-tutte-le-donne-laccesso-ai-test-e-alle-cure-innovative/ 2024-09-17T14:25:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-nerandomilast-soddisfa-endpoint-primario-in-studio-fase-iii-su-fibrosi-polmonare-idiopatica/ 2024-09-18T10:20:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-anche-la-fda-approva-ebglyss-per-il-trattamento-della-dermatite-atopica/ 2024-09-18T08:26:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-un-gruppo-di-harvard-misura-limpatto-e-il-valore-dei-nuovi-trattamenti/ 2024-09-18T09:32:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leo-pharma-ok-aifa-a-tralokinumab-negli-adolescenti-con-da-da-moderata-a-grave/ 2024-09-18T12:32:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-bruno-sepodes-e-il-nuovo-presidente-del-chmp/ 2024-09-18T14:05:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dalla-robotica-allai-la-classifica-mondiale-newsweek-degli-ospedali-piu-smart-humanitas-primo-italiano/ 2024-09-18T14:30:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cattani-farmindustria-competitivita-produttivita-e-la-societa-valori-in-cui-lindustria-farmaceutica-si-riconosce/ 2024-09-18T14:46:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-in-italia-una-storia-lunga-125-anni-per-loccasione-una-campagna-corporate-ispirata-al-tricolore/ 2024-09-18T15:32:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-aifa-approva-rimborsabilita-di-deucravacitinib-nella-psoriasi-a-placche-da-moderata-a-severa/ 2024-09-19T09:59:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-la-triplice-terapia-per-la-bpco-passa-a-un-nuovo-propellente-super-ecologico/ 2024-09-19T12:33:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sburocratizzazione-rapidita-e-respiro-internazionale-per-laifa-robert-nistico-tira-le-somme-di-6-mesi-di-presidenza/ 2024-09-19T12:56:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/organon-acquisisce-dermavant-filiale-dermatologica-di-roivant/ 2024-09-19T13:37:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-accordo-con-nanovation-per-farmaci-genetici-per-malattie-rare-e-cardiometaboliche/ 2024-09-20T08:40:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-gilead-esce-dalla-joint-venture-cinese-con-fosun-pharma-per-le-terapie-cart/ 2024-09-20T12:31:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-tolebrutinib-ritarda-il-tempo-di-insorgenza-della-disabilita-nella-nrspms/ 2024-09-20T12:41:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chmp-nella-riunione-di-settembre-via-libera-a-otto-nuovi-farmaci/ 2024-09-20T13:16:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melanoma-in-stadio-avanzato-dati-di-follow-up-a-10-anni-mostrano-beneficio-di-sopravvivenza-continuo-e-duraturo-con-nivolumab-in-associazione-ad-ipilimumab/ 2024-09-20T14:25:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-via-libera-fda-a-isatuximab-nel-mieloma-multiplo-di-nuova-diagnosi/ 2024-09-23T07:57:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-una-campagna-di-comunicazione-per-la-salute-cardiovascolare/ 2024-09-23T15:15:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-lancia-negli-usa-il-suo-primo-prodotto-per-la-salute-digitale/ 2024-09-23T12:40:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/influenza-via-libera-negli-usa-al-primo-vaccino-fai-da-te/ 2024-09-23T13:56:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cardiomiopatia-ipertrofica-ostruttiva-al-via-da-milano-la-campagna-fai-posto-al-cuore/ 2024-09-23T10:08:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ce-ok-a-zolbetuximab-astellas-in-associazione-a-chemioterapia-per-il-trattamento-del-carcinoma-gastrico-e-della-giunzione-gastroesofagea-in-fase-avanzata/ 2024-09-23T12:39:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-autorizza-nuovo-algoritmo-per-la-mappatura-della-fibrillazione-atriale/ 2024-09-24T07:48:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-accordo-da-27-milioni-di-dollari-per-candidato-patologie-del-snc/ 2024-09-24T10:10:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/automedicazione-ecco-i-prodotti-piu-venduti-in-farmacia/ 2024-09-24T08:42:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanita-digitale-investire-024-dollari-per-paziente-allanno-in-telemedicina-salvera-2-milioni-di-vite-da-malattie-non-trasmissibili-nel-prossimo-decennio-il-rapporto-omsitu/ 2024-09-24T09:13:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-quore-a-cuore-al-via-la-campagna-novartis-per-gestire-il-post-infarto-e-riavere-un-cuore-sano/ 2024-09-24T14:01:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-week-2024-cattani-farmindustria-di-23-000-medicinali-in-sviluppo-nel-mondo-il-45-e-di-origine-biotecnologica/ 2024-09-24T13:39:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beckman-coulter-la-lotta-alla-sepsi-parte-in-laboratorio-dal-biomarcatore-mdw/ 2024-09-24T15:28:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-accordo-con-lonza-per-distribuzione-globale-terapia-car-t-casgevy/ 2024-09-25T08:16:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-il-chmp-dellema-raccomanda-benralizumab-per-il-trattamento-della-egpa/ 2024-09-25T08:44:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-arrivano-i-test-tags-per-il-rilevamento-dei-patogeni/ 2024-09-25T09:46:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibioticoresistenza-nella-ue-ogni-anno-almeno-35mila-decessi-kyriakides-la-minaccia-e-urgente-dobbiamo-intensificare-le-azioni-per-ridurla/ 2024-09-25T12:15:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stagione-influenzale-20242025-csl-seqirus-avvia-la-fornitura-di-vaccini-antinfluenzali-alle-regioni-italiane/ 2024-09-26T15:00:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-soluzioni-allinsegna-di-ai-e-3d-per-una-cardiologia-sempre-piu-efficace/ 2024-09-25T14:10:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bollino-farmaceutico-nistico-aifa-italia-deve-conformarsi-a-normativa-ue-entro-il-9-febbraio-2025-in-corso-lavoro-su-decreto-legislativo/ 2024-09-25T15:30:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/reinert-pfizer-nuova-pandemia-ci-sara-ma-ora-siamo-pronti-a-produrre-vaccini-velocemente/ 2024-09-26T08:18:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-del-seno-esce-oggi-il-trailer-di-distances-la-vita-va-avanti-piu-lontano-docuserie-con-6-storie/ 2024-09-26T10:15:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-offerte-da-societa-di-private-equity-per-la-consumer-health-unit/ 2024-09-26T12:13:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-un-cortometraggio-per-raccontare-il-percorso-del-paziente-cart/ 2024-09-26T14:27:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-da-coorte-tedesca-studio-milos-ottimi-risultati-per-lacido-bempedoico-nella-riduzione-dei-livelli-c-ldl/ 2024-09-27T08:48:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-agli-asiatici-piace-gilead/ 2024-09-27T10:12:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-per-ozanimod-efficacia-duratura-e-sicurezza-costante-nelle-forme-recidivanti-di-sclerosi-multipla/ 2024-09-27T14:38:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-italia-liberiamo-la-circolazione-del-colesterolo-flash-mob-a-roma-sul-rischio-cardiovascolare/ 2024-09-30T13:02:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-lancia-in-italia-pyzchiva-biosimilare-di-ustekinumab/ 2024-09-30T13:02:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-aifa-approva-la-rimborsabilita-di-epcoritamab-nel-linfoma-diffuso-a-grandi-cellule-b-recidivato-o-refrattario/ 2024-09-30T10:21:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nella-sclerosi-multipla-recidivante-ofatumumab-conferma-benefici-in-prima-linea-e-nello-switch-terapeutico/ 2024-09-30T12:05:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-gruppo-chiesi-apre-le-porte-del-nuovo-biotech-center-of-excellence/ 2024-09-30T13:11:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stada-health-report-2024-cala-la-soddisfazione-degli-italiani-verso-il-ssn-ma-il-40-si-fida-di-medici-e-farmacisti/ 2024-09-30T15:04:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-la-fda-approva-cobenfy-nuovo-trattamento-per-la-schizofrenia-dopo-30-anni/ 2024-10-01T09:34:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-la-commissione-europea-approva-pillola-due-in-una-per-la-pah/ 2024-10-01T12:56:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-ottimi-risultati-dallo-studio-trimm2-per-talquetamab-e-daratumumab-nel-mieloma-multiplo-recidivato-o-refrattario/ 2024-10-01T14:33:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-collaborazione-con-tempus-ai-per-la-pipeline-oncologica/ 2024-10-01T14:38:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-roche-acquisisce-portfolio-di-inibitori-cdk-da-regor-therapeutics/ 2024-10-01T15:18:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-polygon-angelo-maresca-e-il-nuovo-amministratore-delegato/ 2024-10-02T08:24:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dolore-oncologico-gli-esperti-farmaci-oppioidi-insostituibili-per-far-vivere-meglio-e-piu-a-lungo-i-pazienti-focus-sul-fentanyl/ 2024-10-02T09:07:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-accordo-miliardario-con-prime-per-sviluppare-terapie-a-base-di-cellule-t/ 2024-10-02T09:08:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-2-miliardi-di-dollari-per-uno-stabilimento-di-prodotti-biologici-nella-carolina-del-nord/ 2024-10-02T09:36:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-stemline-da-aifa-ok-a-rimborsabilita-per-selinexor-nel-mm-disponibile-anche-tagraxofusp-per-la-neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche/ 2024-10-02T12:25:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/radiofarmaci-sperimentali-irst-dino-amadori-di-meldola-ottiene-da-aifa-lautorizzazione-alla-produzione/ 2024-10-02T15:45:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-firma-accordi-di-licenza-volontari-senza-royalty-con-sei-produttori-di-farmaci-generici/ 2024-10-03T07:19:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-ancora-un-investimento-in-rd-e-produzione-nasce-lilly-medicine-foundry/ 2024-10-03T12:07:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-inaugurato-il-nuovo-polo-biotech-a-rieti/ 2024-10-03T13:54:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ferring-un-sito-in-finlandia-dedicato-alla-produzione-della-terapia-genica-per-il-cancro-alla-vescica/ 2024-10-04T08:46:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-del-polmone-ai-telemedicina-e-cambiamenti-di-processo-per-migliorare-lassistenza-la-partnership-tra-int-milano-msd-italia-e-school-of-management-del-politecnico/ 2024-10-04T10:33:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-imprese-al-governo-cancellare-dalla-legge-di-bilancio-il-payback-sui-dm/ 2024-10-04T14:04:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-20-richieste-autorizzazioni-nuovi-medicinali-nei-primi-6-mesi-del-2024/ 2024-10-07T07:17:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sperimentazioni-cliniche-insediato-il-nuovo-centro-di-coordinamento-nazionale-dei-comitati-etici/ 2024-10-07T12:17:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/psoriasi-del-cuoio-capelluto-nuovi-studi-confermano-efficacia-deucravacitinib/ 2024-10-07T12:21:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nobel-per-la-medicina-2024-a-victor-ambros-e-gary-ruvkun-per-i-loro-studi-sui-microrna/ 2024-10-07T12:26:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hpv-loms-aggiunge-un-nuovo-vaccino-per-luso-monodose/ 2024-10-07T12:27:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-completa-lacquisizione-di-jnana-therapeutics/ 2024-10-08T08:15:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-acquisisce-i-diritti-mondiali-di-enjaymo-sanofi/ 2024-10-08T08:37:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-anticorpo-bispecifico-teclistamab-rimborsato-in-italia/ 2024-10-08T09:10:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beckman-coulter-e-scopio-labs-accordo-per-la-distribuzione-del-primo-sistema-al-mondo-di-imaging-e-analisi-digitale-del-midollo-osseo/ 2024-10-08T09:36:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-ok-aifa-a-cemiplimab-nel-nsclc-e-nel-cancro-della-cervice-uterina/ 2024-10-08T12:04:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/virus-respiratorio-sinciziale-vaccino-gsk-si-dimostra-protettivo-per-3-stagioni-negli-over-60/ 2024-10-08T12:03:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-una-survey-internazionale-sul-legame-tra-hpv-e-tumore-alla-cervice-uterina/ 2024-10-08T13:44:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-arriva-in-italia-tirzepatide-nuovo-trattamento-per-obesita-e-diabete/ 2024-10-09T09:18:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ascendis-pharma-sbarca-in-italia-la-sede-operativa-e-a-milano/ 2024-10-09T10:20:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-aifa-punta-sullinformazione-indipendente-nasce-cosisifa/ 2024-10-09T12:16:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-partnership-con-moma-therapeutics-per-nuovo-programma-oncologico-di-precisione/ 2024-10-09T12:43:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-opzione-su-un-candidato-di-aviadobio-per-la-demenza-frontotemporale/ 2024-10-09T13:29:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asma-grave-e-poliposi-nasale-gli-esperti-anti-il-5-efficace-contro-le-due-patologie-hanno-lo-stesso-percorso-infiammatorio/ 2024-10-09T14:07:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/si-rinnova-la-strategia-della-rete-delle-agenzie-farmaceutiche-europee-fino-al-2028-al-via-la-consultazione-pubblica/ 2024-10-09T14:47:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/depressione-gli-italiani-la-conosco-la-temono-ma-non-la-considerano-una-malattia-lindagine-swg-in-collaborazione-con-jj-innovative-medicine/ 2024-10-10T10:45:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-oncologici-report-ocse-da-100-giorni-a-3-anni-in-europa-per-arrivare-ai-pazienti/ 2024-10-10T09:28:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-arriva-il-chief-ai-officer/ 2024-10-10T10:08:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-investe-nelle-terapie-basate-sui-fibroblasti-accordo-con-mestag-therapeutics/ 2024-10-10T12:58:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/conflitti-di-interesse-ema-lancia-consultazione-pubblica-su-revisione-della-sua-politica-interna/ 2024-10-10T13:23:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-lancia-morpho-la-nuova-brand-identity-della-business-unit-cdmo/ 2024-10-10T14:28:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-impianto-per-i-test-di-biosicurezza-nel-maryland/ 2024-10-11T08:01:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-fda-a-inavolisib-nel-cancro-mammario/ 2024-10-11T08:48:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/forme-farmaceutiche-siamo-pronti-per-le-gomme-masticabili/ 2024-10-11T10:08:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-partner-di-tennis-friends-salute-e-sport/ 2024-10-11T12:51:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/un-migliore-utilizzo-dei-vaccini-potrebbe-ridurre-luso-di-antibiotici-di-25-miliardi-di-dosi-allanno-il-nuovo-report-delloms/ 2024-10-11T13:10:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/osteogenesi-imperfetta-focus-dellimpact-survey-in-66-paesi-i-dati-italiani/ 2024-10-11T15:13:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ok-chmp-ad-aggiornamento-scheda-tecnica-di-semaglutide-24-per-la-riduzione-dei-sintomi-dellinsufficienza-cardiaca/ 2024-10-14T09:31:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-un-sito-in-cina-dedicato-a-tirzepatide/ 2024-10-14T12:52:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-fda-approva-marstacimab-nellemofilia/ 2024-10-14T13:23:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-da-un-think-thank-proposte-per-una-moderna-gestione-multidisciplinare/ 2024-10-14T15:36:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/together-days-gsk-il-volontariato-dimpresa-incontra-le-comunita-locali/ 2024-10-14T15:54:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-acquisisce-la-biotech-usa-longboard-pharmaceuticals/ 2024-10-15T09:08:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-biotech-investe-nella-piattaforma-biologica-di-xtalpi/ 2024-10-15T09:36:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-ocse-in-meta-dei-paesi-ci-sono-accordi-riservati-e-barriere-alla-trasparenza-servono-azioni-politiche/ 2024-10-15T12:19:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farma-mese-e-panorama-cosmetico-online-editoriale-giornalidea-accelera-sulla-digitalizzazione-del-mondo-farmacia/ 2024-10-17T12:55:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/con-phaser-nasce-un-modello-predittivo-per-lappropriatezza-e-linnovazione-nella-governance-del-farmaco/ 2024-10-15T17:23:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-aic-allema-per-elinzanetant-nel-trattamento-dei-sintomi-della-menopausa/ 2024-10-16T08:41:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-trimestre-record-per-darzalex-daratumumab/ 2024-10-16T12:14:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotecnologie-schillaci-in-futuro-50-dei-farmaci-sara-biotech/ 2024-10-16T13:50:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-jj-presenta-domanda-approvazione-formulazione-sottocutanea-di-daratumumab-nella-terapia-quadrupla-del-mm/ 2024-10-16T15:23:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celltrion-ottima-risposta-per-infliximab-sottocutaneo-nelle-ibd/ 2024-10-17T10:19:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-equivalenti-osservatorio-nomisma-dal-2012-hanno-fatto-risparmiare-62-miliardi-al-ssn/ 2024-10-17T15:09:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-italia-il-mimit-la-celebra-con-un-francobollo/ 2024-10-17T14:52:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-nuovi-importanti-risultati-per-il-vaccino-coniugato-pneumococcico-21valente-v116-dallo-studio-stride8/ 2024-10-17T15:53:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-societa-con-orano-med-per-terapie-con-radioligandi-a-base-di-piombo212/ 2024-10-18T08:55:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bpco-mercato-da-30-mld-di-dollari-entro-il-2033/ 2024-10-18T12:33:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-parere-positivo-chmp-a-ribociclib-nel-tumore-al-seno-precoce-hrher2/ 2024-10-18T14:35:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-fda-approva-zolbetuximab-nel-trattamento-del-cancro-gastrico/ 2024-10-21T09:13:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-rimborsabilita-in-italia-per-atogepant-nella-prevenzione-dellemicrania/ 2024-10-21T10:21:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-le-associazioni-urgente-un-tavolo-tecnico-sul-payback/ 2024-10-21T10:47:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-la-vendita-di-opella-e-piu-vicina-trattative-esclusive-con-clayton-dubilier-rice/ 2024-10-22T09:22:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-chmp-raccomanda-concizumab-come-trattamento-preventivo-nellemofilia/ 2024-10-22T09:47:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-clesrovimab-riduce-incidenza-da-malattia-da-rsv-e-ospedalizzazione-nei-neonati-sani-prematuri-e-a-termine/ 2024-10-22T15:18:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/societa-scientifiche-associazioni-di-pazienti-e-istituzioni-firmano-il-patto-per-leliminazione-dellepatite-c-parola-dordine-prorogare-lo-screening-gratuito-a-tutto-il-202/ 2024-10-22T15:59:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-gilead-funziona-la-combo-islatravir-lenacapavir-nel-trattamento-dellhiv-una-volta-a-settimana/ 2024-10-23T08:50:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sindrome-cardio-renale-metabolica-un-osservatorio-per-convalidare-i-migliori-modelli-di-prevenzione-e-presa-in-carico/ 2024-10-23T08:53:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/premio-angelo-zanibelli-ecco-i-vincitori-2024-del-riconoscimento-letterario-la-parola-che-cura/ 2024-10-23T09:36:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-aifa-approva-rimborsabilita-di-pirtobrutinib-nel-linfoma-mantellare/ 2024-10-23T09:57:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-celebra-i-40-anni-dello-stabilimento-di-alanno/ 2024-10-23T12:11:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-la-docuserie-distances-la-vita-va-avanti-piu-lontano-presentata-alla-festa-del-cinema-di-roma/ 2024-10-23T14:25:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manovra-doccia-fredda-per-il-pharma-non-aumenta-il-tetto-di-spesa-ecco-le-misure-per-la-farmaceutica/ 2024-10-24T06:54:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-commissione-europea-approva-formulazione-sottocutanea-di-daratumumab-jj/ 2024-10-24T09:01:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-a-mrna-accordi-di-licenza-cresciuti-dell800-in-5-anni/ 2024-10-24T09:59:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confalone-novartis-primo-ospite-di-future-in-healthcare-scienze-della-vita-punta-di-diamante-da-sostenere-con-adeguata-politica-industriale/ 2024-10-25T08:08:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/efpia-e-vaccines-europe-allarme-sperimentazione-clinica-in-europa-si-e-dimezzata-in-un-decennio/ 2024-10-24T13:21:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-seno-alla-festa-del-cinema-di-roma-un-incontro-promosso-dallintergruppo-parlamentare-nuove-frontiere-terapeutiche-nei-tumori-della-mammella/ 2024-10-24T14:35:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-800-milioni-di-dollari-per-espansione-produttiva-in-pennsylvania/ 2024-10-25T08:28:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regno-unito-nuovo-quadro-normativo-permettera-produzione-farmaci-innovativi-presso-il-luogo-di-cura-del-paziente/ 2024-10-25T09:37:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-congresso-siti-assistente-sanitario-non-sottovalutare-quelli-raccomandati/ 2024-10-25T14:09:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-e-gedeon-richter-collaborazione-nella-neuropsichiatria/ 2024-10-28T09:31:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rischio-cardiovascolare-al-femminile-le-donne-italiane-lo-sottostimano/ 2024-10-28T11:52:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-torna-together-against-rsv-campagna-di-informazione-sul-virus-respiratorio-sinciziale-nei-bambini-nel-loro-primo-anno-di-vita/ 2024-10-28T13:54:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-landazabal-gsk-italia-con-coperture-ottimali-il-pil-potrebbe-crescere-di-oltre-10-mld/ 2024-10-29T09:56:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-un-patto-per-luso-del-digitale-e-dellia/ 2024-10-29T10:25:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-action-paper-partner-per-il-futuro-proposte-per-migliorare-il-ssn/ 2024-10-29T11:31:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-acquisisce-aliad-therapeutics-biotech-specializzata-nel-snc/ 2024-10-29T14:08:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/associazioni-pazienti-e-comunita-medico-scientifica-con-confindustria-dm-appello-a-meloni-no-al-payback-sui-dispositivi-medici/ 2024-10-29T14:48:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccinazioni-nella-campagna-2023-2024-italia-solo-al-16-posto-in-europa-per-coperture-contro-il-covid-tra-gli-over-80/ 2024-10-30T09:09:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mercato-dei-farmaci-in-farmacia-continua-il-trend-in-crescita-tachipirina-saldamente-in-testa-ma-continua-la-performance-da-record-dei-farmaci-antidiabete/ 2024-10-31T08:57:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dupilumab-nellorticaria-cronica-spontanea-nuovi-dati-positivi-di-fase-3-presentati-allacaai/ 2024-10-30T12:15:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tubercolosi-oms-e-tornata-la-peggiore-minaccia-infettiva-mortale-al-mondo-82-mln-di-nuove-diagnosi-nel-2023/ 2024-10-30T12:24:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/granulomatosi-eosinofila-con-poliangite-egpa-benralizumab-approvato-nellunione-europea/ 2024-10-30T14:28:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-la-campagna-educazionale-dal-palato-alla-tiroide-focus-su-alimentazione-e-disturbi-tiroidei/ 2024-10-31T08:37:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/survey-sulle-associazioni-di-pazienti-sentono-crescere-la-loro-influenza-su-enti-regolatori-media-e-altri-stakeholder/ 2024-10-31T08:53:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mpox-due-nuovi-test-entrano-nellelenco-emergency-use-listing/ 2024-10-31T09:18:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nistico-aifa-per-velocizzare-laccesso-ai-farmaci-potenziare-e-qualificare-gli-organici-dellagenzia/ 2024-10-31T10:26:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-commissione-ue-maxi-multa-da-462-milioni-di-euro-a-teva-per-abusi-su-brevetti-farmaco-contro-la-sclerosi-multipla/ 2024-10-31T13:26:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-partnership-con-dyno-therapeutics-per-nuove-terapie-geniche-nelle-patologie-neurologiche/ 2024-11-04T09:36:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-semaglutide-funziona-anche-nella-mash/ 2024-11-04T10:21:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/luppi-msd-linnovazione-farmaceutica-non-puo-essere-limitata-a-6-anni-ce-ancora-tempo-per-perfezionare-la-legge-di-bilancio/ 2024-11-04T13:17:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sicurezza-dei-farmaci-aifa-partecipa-alla-medsafetyweek-202/ 2024-11-04T15:14:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/barni-confindustria-dm-bloccare-payback-futuro-e-rimodulare-i-tetti-di-spesa-sulla-media-europea/ 2024-11-04T13:49:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/torna-scanner-orizzonti-a-milano-il-13-dicembre-si-parlera-di-datamatrix-ai-distribuzione/ 2024-11-05T09:25:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-partnership-con-bmc-per-obiettivo-carbon-zero-negli-usa/ 2024-11-05T09:49:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-forte-ripresa-delle-vendite-del-vaccino-anti-covid-nel-q3/ 2024-11-05T10:30:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-parte-la-campagna-abituati-a-proteggerti-sulle-infezioni-respiratorie-stagionali/ 2024-11-05T15:29:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-accordo-miliardario-con-monte-rosa-therapeutics-per-degradatori-di-colla-molecolare/ 2024-11-06T10:25:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-health-nice-approva-due-sistemi-di-monitoraggio-da-remoto-dellinsufficienza-cardiaca/ 2024-11-06T10:52:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-gruppo-esaote-espande-la-produzione-in-india/ 2024-11-06T11:46:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-pharma-piace-sempre-di-piu-lai-soprattutto-in-europa/ 2024-11-06T14:46:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ema-approva-dupilumab-nei-bambini-con-esofagite-eosinofila/ 2024-11-07T11:19:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-alexion-astrazeneca-rare-disease-via-libera-da-aifa-a-rimborsabilita-di-ravulizumab-nella-gmg/ 2024-11-08T10:01:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-q3-a-trazione-semaglutide-ma-avanza-la-concorrenza/ 2024-11-07T14:30:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-is-back-cosa-cambia-per-lindustria-farmaceutica-al-di-qua-dellatlantico-lopinione-di-emma-walmsley-ceo-di-gsk/ 2024-11-07T15:32:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hassabis-premio-nobel-chimica-2024-lai-rivoluzionera-la-scoperta-dei-farmaci/ 2024-11-08T13:24:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-urgente-integrare-la-salute-nei-negoziati-sul-clima-in-vista-della-cop29/ 2024-11-08T16:48:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-collaborazione-con-alteogen-per-la-formulazione-sottocutanea-di-trastuzumab-deruxtecan/ 2024-11-11T10:23:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-la-scarsa-aderenza-alle-terapie-costa-2-miliardi-lanno-al-via-il-tavolo-su-medicina-di-precisione-e-prescrittomica-per-migliorarla/ 2024-11-11T11:13:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-autorizzato-nella-ue-vaccino-antinfluenzale-trivalente-ad-alto-dosaggio/ 2024-11-12T11:04:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-dallo-studio-paso-doble-emerge-efficacia-del-regime-a-due-farmaci-dtg-3tc/ 2024-11-11T16:17:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-dupilumab-rimborsabile-per-quattro-nuove-indicazioni/ 2024-11-12T10:59:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-progetto-primary-site-barni-costruiamo-insieme-un-ecosistema-collaborativo-con-universita-istituzioni-enti-di-ricerca-investitori-e-startup/ 2024-11-12T11:40:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-rapporto-osmed-volano-i-consumi-di-antiobiotici-e-dimagranti/ 2024-11-12T15:30:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-homnyaceutical-lomnicanalita-integrata-che-rivoluziona-il-modello-di-comunicazione-a-medico-e-farmacista/ 2024-11-13T09:31:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-oltre-3-mld-di-euro-per-potenziare-ricerca-e-produzione-negli-usa/ 2024-11-13T10:06:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/reuters-pfizer-pronta-a-cedere-il-business-dei-farmaci-ospedalieri/ 2024-11-13T11:44:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-accordo-con-la-startup-vesalius-therapeutics-per-scoprire-nuovi-farmaci-per-il-parkinson/ 2024-11-14T10:05:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-acquisisce-la-pharma-cinese-biotheus-nel-mirino-un-candidato-innovativo/ 2024-11-14T10:47:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-cattani-sanofi-dopo-vittoria-trump-per-leuropa-e-lultima-chiamata-su-competitivita-e-investimento-in-innovazione/ 2024-11-14T13:37:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beigene-cambia-il-proprio-nome-in-beone-medicines/ 2024-11-14T15:17:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogeneisai-chmp-dellema-ora-raccomanda-lecanemab-per-la-terapia-dellalzheimer/ 2024-11-15T10:18:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-il-no-vax-robert-f-kennedy-jr-a-capo-dellhhs/ 2024-11-15T11:21:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-accordo-con-la-cinese-lanova-per-un-candidato-anticorpo-bispecifico/ 2024-11-15T14:10:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-studio-dreamm7-nuovi-risultati-positivi-per-belantamab-mafodotin/ 2024-11-18T09:33:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/radioligandi-orano-med-investe-250-mln-di-euro-per-un-impianto-in-francia/ 2024-11-18T10:08:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-chmp-raccomanda-isatuximab-nei-pazienti-ndmm-non-idonei-al-trapianto/ 2024-11-18T12:02:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carcinoma-endometriale-al-via-il-progetto-smart-ptda/ 2024-11-18T13:16:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-tirzepatide-efficace-anche-nella-prevenzione-del-diabete-di-tipo-2/ 2024-11-18T15:10:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-dalla-partnership-con-quell-therapeutics-una-terapia-treg/ 2024-11-19T13:11:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-partnership-radiofarmaceutica-con-ratio-therapeutics/ 2024-11-19T10:38:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/decreto-tariffe-confindustria-dm-bene-nuovi-lea-ma-aggiornamento-sia-continuo/ 2024-11-19T11:40:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-tezepelumab-riduce-la-dimensione-dei-polipi-nasali-e-la-congestione-nasale-nella-crswnp/ 2024-11-19T13:09:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-nuovo-sito-produttivo-allavanguardia-in-irlanda/ 2024-11-19T14:11:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-a-laura-nocerino-la-guida-della-rare-bu/ 2024-11-19T15:22:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-biosimilari-verso-una-corretta-attuazione-della-legge-232-2016-per-mitigare-il-fenomeno-delle-carenze/ 2024-11-20T10:28:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-lintergruppo-parlamentare-innovazione-sanitaria-e-tutela-del-paziente/ 2024-11-20T13:18:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-la-formulazione-sottocutanea-di-pembrolizumab-simile-a-quella-endovenosa/ 2024-11-20T13:38:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/depressione-un-labirinto-da-cui-si-puo-uscire-a-milano-un-evento-jj-innovative-medicine/ 2024-11-20T14:49:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/globaldata-nel-2033-oltre-3-milioni-di-casi-nei-7mm-italia-paese-con-limpatto-minore/ 2024-11-21T13:12:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-da-gennaio-2025-chris-boshoff-nuovo-chief-scientific-officer/ 2024-11-21T10:55:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-italia-18-in-europa-per-risorse-ma-alto-il-livello-dei-trial/ 2024-11-21T14:20:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-acquisisce-kate-therapeutics-e-aumenta-le-previsioni-di-vendita/ 2024-11-22T09:55:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-mpox-ok-a-vaccino-km-biologics-per-luso-di-emergenza-potra-essere-somministrato-anche-ai-bambini-maggiori-di-un-anno/ 2024-11-22T14:19:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-siglato-un-action-paper-per-un-accesso-equo-tempestivo-e-sostenibile-alle-nuove-tecnologie/ 2024-11-22T15:17:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-howard-chang-e-il-nuovo-chief-scientific-officer/ 2024-11-25T16:20:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-sceglie-il-chirurgo-marty-makary-per-guidare-la-fda/ 2024-11-25T16:52:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-da-ce-via-libera-a-marstacimab-nellemofilia-a-o-b-grave-senza-inibitori/ 2024-11-25T13:46:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-50-anni-di-presenza-in-europa/ 2024-11-26T16:38:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-sul-podio-del-q3/ 2024-11-26T16:34:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-italia-contro-la-violenza-sulle-donne/ 2024-11-26T14:40:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-barni-confindustria-dm-un-miliardo-lanno-di-payback-vale-riduzione-del-pil-da-860-milioni/ 2024-11-26T16:47:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-accanto-a-fai-nel-progetto-bene-fai-per-tutti/ 2024-11-26T17:21:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-antidepressivi10-vendite-fra-i-giovani-nellultimo-anno-e-il-giro-daffari-supera-il-mezzo-miliardo-di-euro/ 2024-11-27T08:23:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-ce-a-mirvetuximab-soravtansine-nel-trattamento-del-tumore-ovarico-platinoresistente/ 2024-11-27T10:13:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-acquisisce-poseida-therapeutics-e-rafforza-la-pipeline-cart/ 2024-11-27T13:52:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beigene-la-ce-approva-tislelizumab-nellescc-e-nel-ggej/ 2024-11-27T15:42:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-a-singapore-un-impianto-modulare-per-vaccini-e-farmaci-biologici/ 2024-11-28T11:09:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ocaliva-tribunale-unione-europea-non-proroga-sospensione-decisione-ce-di-revoca-allimmissione-in-commercio-condizionata-la-risposta-di-advanz-pharma/ 2024-11-28T16:28:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-ce-a-ribociclib-nel-trattamento-in-fase-adiuvante-del-tumore-della-mammella-precoce-hrher2/ 2024-11-28T13:30:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/governance-farmaceutica-dal-national-summit-un-appello-per-un-coordinamento-centrale-a-garanzia-dellequita-di-accesso/ 2024-11-28T13:42:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-scarsa-informazione-pochi-test-e-tanto-stigma-il-libro-bianco-di-gilead/ 2024-11-28T15:09:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-aifa-invita-gli-stakeholder-a-proporre-aree-di-studio-sui-medicinali/ 2024-11-28T15:16:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/resilienza-del-sistema-sanitario-italiano-arriva-il-barometro-pubblicato-da-bd/ 2024-11-29T11:05:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-glp1r-contro-lobesita-a-quando-la-prima-ad-assunzione-orale/ 2024-11-29T14:14:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-astrazeneca-italia-centrale-per-le-life-science/ 2024-11-29T15:26:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-neo-cfo-chiara-borinelli-entra-nel-consiglio-di-amministrazione-di-sanofi-in-italia/ 2024-12-02T10:12:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-a-berlino-il-primo-incubatore-europeo-per-le-life-science/ 2024-12-02T10:58:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-la-ce-approva-formulazione-liquida-del-vaccino-menveo-per-la-imd/ 2024-12-02T11:20:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-arriva-mallya-per-una-gestione-smart-del-diabete/ 2024-12-02T12:00:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-lancia-esmp-piattaforma-per-la-gestione-delle-carenze-di-farmaci-nellue/ 2024-12-02T14:08:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hta-a-roma-il-patient-advocacy-network-focus-sul-ruolo-delle-associazioni-dei-pazienti-nel-quadro-del-nuovo-regolamento-europeo/ 2024-12-02T15:15:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-sm-e-sessualita-stop-ai-tabu/ 2024-12-02T16:21:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-continua-a-scommettere-sulla-cina-un-miliardo-di-euro-per-un-sito-che-produrra-insulina/ 2024-12-03T10:10:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-accordo-monstre-un-miliardo-di-dollari-a-ptc-therapeutics-per-candidato-contro-la-malattia-di-huntington/ 2024-12-03T10:43:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-tumore-al-polmone-on-line-si-parla-soprattutto-di-terapie-il-fondo-per-i-farmaci-innovativi-italiano-modello-per-leuropa/ 2024-12-03T11:46:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-lilly-italia-il-transatlantic-award-dellamerican-chamber-of-commerce-in-italy/ 2024-12-03T14:31:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-e-olema-oncology-partnership-per-studio-combo-tumore-al-seno/ 2024-12-04T10:31:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-acquisisce-longboard-pharma/ 2024-12-04T11:48:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obesita-al-via-campagna-cittadinanzattiva-federfarma-materiale-informativo-e-valutazione-del-rischio-nelle-farmacie/ 2024-12-04T14:07:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-progetto-di-sensibilizzazione-per-promuovere-la-prevenzione-ginecologica/ 2024-12-04T15:21:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/michela-ferri-alla-guida-della-business-unit-oncology-hematology-di-incyte-italia/ 2024-12-05T15:49:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-italia-celebra-la-giornata-mondiale-del-volontariato-con-drive-a-change/ 2024-12-05T10:02:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-un-hub-per-il-controllo-di-qualita/ 2024-12-05T10:35:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genmab-espande-la-sua-pipeline-grazie-a-un-accordo-con-scancell-da-630-milioni-di-dollari/ 2024-12-05T15:52:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-dal-congresso-simit-nuove-evidenze-per-la-terapia-antiretrovirale-sempre-piu-verso-trattamenti-personalizzati/ 2024-12-05T14:00:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-oncologia-arriva-in-italia-atezolizumab-sottocute/ 2024-12-05T15:29:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-punta-su-una-startup-belga-per-un-farmaco-contro-lalzheimer/ 2024-12-06T10:16:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-3-miliardi-di-dollari-per-espandere-lo-stabilimento-di-iniettabili-del-wisconsin/ 2024-12-06T10:57:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-iptacopan-migliora-i-livelli-di-emoglobina-nei-pazienti-adulti-con-epn-precedentemente-trattati-con-terapie-antic5/ 2024-12-06T13:28:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutico-in-italia-settore-locomotiva-frenato-dal-payback/ 2024-12-10T07:02:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-studio-surmount5-tirzepatide-superiore-a-semaglutide-nella-perdita-di-peso/ 2024-12-09T10:21:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-diabete-arriva-in-italia-nuovo-sistema-integrato-per-lerogazione-automatica-di-insulina/ 2024-12-09T11:25:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-holdings-catalent-via-libera-ce-al-closing-dellacqusizione/ 2024-12-09T15:01:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-nuove-linee-guida-per-lapprovazione-accelerata-dei-farmaci/ 2024-12-09T15:41:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-ottimi-risultati-per-belantamab-mafodotin-mm-nello-studio-dreamm7/ 2024-12-10T11:54:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-un-passo-avanti-nella-sensibilizzazione-sul-diabete-autoimmune-di-tipo-1/ 2024-12-10T13:43:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/salute-mentale-unemergenza-silenziosa-e-sottostimata-ecco-limpegno-unanime-con-lagenda-2025/ 2024-12-10T14:32:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccinazioni-per-adulti-e-anziani-come-migliorare-la-protezione-abbattendo-i-costi/ 2024-12-11T09:31:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nuovi-dati-positivi-per-le-quadriplette-a-base-di-isatuximab-nei-pazienti-con-mieloma-multiplo-di-nuova-diagnosi/ 2024-12-11T10:35:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aop-health-emanuele-oro-e-il-nuovo-country-manager-italy/ 2024-12-11T10:46:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-lancia-psorridi-campagna-digitale-di-sensibilizzazione-sulla-psoriasi/ 2024-12-11T11:23:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-raccontare-il-futuro-della-medicina-alla-generazione-z-al-via-il-progetto-fattore-j/ 2024-12-11T15:14:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-acalabrutinib-con-venetoclax-migliora-la-sopravvivenza-libera-da-progressione-nella-leucemia-linfatica-cronica-rispetto-alla-chemioterapia/ 2024-12-12T10:23:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manovra-confindustria-dm-bloccare-il-payback-1-impresa-su-5-a-rischio-fallimento-immediato/ 2024-12-12T11:06:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-innovative-medicine-mieloma-multiplo-con-terapia-cart-ciltacel-tassi-di-negativita-della-malattia-minima-residua-significativamente-piu-elevati/ 2024-12-12T11:52:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-si-espande-nel-mercato-dellibs-acquisendo-hidoc-technologies-e-lapp-cara-care/ 2024-12-12T14:11:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/orientare-al-valore-e-ammodernare-le-tecnologie-in-sanita-lambizione-del-progetto-taete/ 2024-12-16T19:16:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ema-approva-faricimab-in-siringa-preriempita-per-tra-patologie-retiniche/ 2024-12-13T10:11:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/science-incorona-lenacapavir-breakthrough-of-the-year/ 2024-12-13T10:37:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/i-vaccini-combinati-di-sanofi-ottengono-la-designazione-fast-track-dalla-fda/ 2024-12-13T11:01:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-con-il-progetto-sicura-dislpipidemie-gestite-meglio-sul-territorio-e-meno-ospedalizzazioni/ 2024-12-16T11:54:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/manovra-lindustria-gia-attenzionata-nelle-precedenti-finanziarie-misura-su-grossisti-per-evitare-crollo-filiera-ma-pensiamo-a-innovativita-farmaci-da-6-a-10-anni-intervista-a-gemmato/ 2024-12-16T10:39:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dietmar-berger-e-il-nuovo-cmo-di-gilead/ 2024-12-16T11:09:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-acquisisce-nimble-spinout-di-roche/ 2024-12-16T11:41:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/conflitto-di-interesse-approvato-dal-cda-aifa-il-nuovo-regolamento-che-vara-la-stretta-ma-apre-a-pareri-e-consulenze-gratuite-dei-professionisti-di-alto-profilo/ 2024-12-16T13:52:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-tre-importanti-via-libera-per-farmaci-gsk-contro-carcinoma-endometriale-del-retto-e-del-polmone/ 2024-12-16T13:51:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-parere-positivo-chmp-per-seladelpar-nella-colangite-biliare-primitiva/ 2024-12-16T14:26:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amarin-da-aifa-rimborsabilita-per-icosapent-etile-nel-trattamento-del-rischio-cardiovascolare-residuo/ 2024-12-16T15:23:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-la-dimensione-sociale-come-valore-di-impresa/ 2024-12-17T10:35:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emendamento-a-finanziaria-per-fondo-prevenzione-e-cura-dellobesita-per-il-triennio-2025-2027/ 2024-12-17T13:43:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-focus-a-milano-sulla-epn/ 2024-12-17T13:54:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-apre-una-sede-a-roma/ 2024-12-18T09:03:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-agora-institute-primo-obiettivo-realizzare-il-testo-unico-della-sanita/ 2024-12-18T11:20:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-12-mld-di-dollari-per-uno-stabilimento-di-produzione-super-green/ 2024-12-18T11:08:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazenecamsd-con-olaparib-88-dei-pazienti-con-tumore-del-seno-precoce-e-mutazione-brca-ancora-in-vita-dopo-6-anni/ 2024-12-18T13:49:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-da-ema-e-hma-un-approccio-comune-alla-trasparenza-dei-dati-nella-regolamentazione-dei-medicinali/ 2024-12-19T08:56:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-accordo-con-terray-therapeutics-per-identificare-nuove-terapie-con-small-molecule/ 2024-12-19T10:26:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-msd-entra-nel-mercato-dei-farmaci-contro-lobesita-accordo-con-la-cinese-hansoh/ 2024-12-19T11:01:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/data-analytics-nuovo-petrolio-anche-nel-farmaceutico-mercato-da-21-mld-di-dollari-entro-il-2028/ 2024-12-19T14:08:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-ok-chmp-ad-acoramidis-nella-cardiomiopatia-amiloide-da-transtiretina/ 2024-12-19T14:37:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-holdings-completa-lacquisizione-di-catalent-per-165-miliardi-di-dollari/ 2024-12-20T09:57:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-accordo-con-bioage-labs-per-le-malattie-legate-allinvecchiamento/ 2024-12-20T10:33:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-biologici-nella-bpco-si-apre-una-nuova-era-per-la-gestione-della-malattia/ 2024-12-20T13:19:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-ed-egualia-confusione-su-applicazione-regolamento-tracciatura-europea-dei-medicinali-rischio-blocco-della-produzione/ 2024-12-20T15:27:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amylyx-sceglie-dan-monahan-per-la-carica-di-chief-commercial-officer/ 2025-01-07T10:52:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-acquisisce-in-irlanda-stabilimento-di-wuxi-biologics/ 2025-01-07T13:33:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-prima-bozza-linee-guida-su-uso-dellai-nello-sviluppo-dei-farmaci/ 2025-01-07T14:14:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beigene-giancarlo-benelli-nuovo-head-of-europe/ 2025-01-08T09:54:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amicus-therapeutics-da-aifa-rimborsabilita-per-combo-cipaglucosidasi-alfa-miglustat-nella-malattia-di-pompe-a-esordio-tardivo/ 2025-01-08T10:17:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-croniche-lo-psicologo-come-supporto-ai-pazienti-una-figura-da-potenziare-attraverso-le-case-della-comunita-collaborazione-con-mmg-e-formazione-2/ 2025-01-08T11:11:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-da-fda-status-di-farmaco-innovativo-per-adc-contro-losteosarcoma/ 2025-01-08T11:58:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-sceglie-alloy-therapeutics-per-lo-sviluppo-di-farmaci-antisenso-per-il-snc/ 2025-01-09T10:00:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-e-orna-therapeutics-collaborazione-triennale-per-terapie-geniche/ 2025-01-09T11:28:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-status-di-farmaco-orfano-per-elraglusib-actuate-therapeutics/ 2025-01-09T11:27:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/foglietto-illustrativo-elettronico-lindustria-farmaceutica-europea-pubblica-raccomandazioni-congiunte/ 2025-01-09T15:58:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-e-variant-bio-collaborazione-per-nuovi-obiettivi-terapeutici-per-il-trattamento-delle-malattie-metaboliche/ 2025-01-10T09:47:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/commissione-europea-estende-immunoterapia-per-allergia-alle-arachidi-ai-bambini-da-uno-a-tre-anni/ 2025-01-10T10:39:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hta-dal-12-gennaio-in-vigore-le-nuove-norme-ue-per-le-valutazioni-delle-tecnologie-sanitarie/ 2025-01-10T16:37:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nuovo-global-capacity-center-in-india/ 2025-01-13T10:31:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-ecco-le-novita-che-ci-attendono-nel-2025-il-dossier-aifa/ 2025-01-13T11:19:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/healthcare-rapporto-svb-gli-investitori-premiano-le-startup-ai/ 2025-01-13T14:21:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cerved-industry-forecast-in-italia-ripartono-esportazioni-e-consumi-anche-grazie-al-pharma-incognita-dazi-usa/ 2025-01-14T11:42:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-primo-colpo-del-2025-acquisita-intra-cellular-therapies-per-146-miliardi-di-dollari/ 2025-01-14T13:53:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsh-shopping-nelloncologia-acquisita-idrx/ 2025-01-14T16:14:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nvidia-iqvia-illumina-e-mayo-clinic-partnership-sulluso-dellai/ 2025-01-14T17:21:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/frederico-da-silva-gilead-prioritario-risanare-effetti-payback-i-nostri-farmaci-sono-made-in-italy-difenderne-valore/ 2025-01-15T11:47:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-acquisisce-i-diritti-di-un-adc-da-glycotope-per-132-milioni-di-dollari/ 2025-01-15T13:46:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-25-mld-di-dollari-per-una-terapia-oncologica-sperimentale/ 2025-01-15T14:35:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grifols-dalla-michael-j-fox-foundation-sovvenzione-da-21-mln-di-dollari-per-la-ricerca-sui-biomarcatori-del-parkinson-nel-plasma/ 2025-01-15T15:29:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rimegepant-contro-lemicrania-dimostra-efficacia-e-tollerabilita-nella-vita-reale/ 2025-01-16T13:44:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-vento-in-poppa-con-una-ricca-pipeline/ 2025-01-16T17:46:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-sei-asset-in-pipeline-da-20-miliardi-di-dollari/ 2025-01-16T17:46:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/istituito-il-tavolo-tecnico-aifa-regioni-per-confronto-continuativo-su-accesso-ai-farmaci-e-rimborsabilita/ 2025-01-16T16:40:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-pharma-brian-heath-e-il-nuovo-head-of-global-commercial/ 2025-01-17T09:41:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sperimentazioni-cliniche-report-aifa-in-italia-611-trial-approvati-nel-2023/ 2025-01-17T11:14:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/homnya-e-sics-annunciano-la-fusione-nasce-la-principale-health-data-marketing-media-company/ 2025-01-20T10:56:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/approvazioni-farmaci-2024-fda-supera-ema/ 2025-01-20T14:08:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-daiichi-sankyo-ok-fda-a-datopotamab-deruxtecan-nel-cancro-della-mammella/ 2025-01-20T14:54:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biden-ultimo-atto-concessa-la-grazia-ad-anthony-fauci/ 2025-01-20T15:42:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shionogi-375-milioni-di-dollari-da-hhs-degli-stati-uniti-per-terapia-pre-esposizione-al-covid19/ 2025-01-21T11:58:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-dalle-terapie-digitali-opportunita-per-il-futuro-del-ssn/ 2025-01-21T14:06:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ivosidenib-disponibile-in-italia-per-colangiocarcinoma-e-lma-con-mutazioni-idh1/ 2025-01-22T18:28:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parkinson-dimostrata-efficacia-della-citicolina-sale-sodico-miglioramento-dei-sintomi-e-della-qualita-di-vita-dei-pazienti/ 2025-01-23T08:02:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ue-approva-isatuximab-nei-pazienti-ndmm-non-eleggibili-a-trapianto/ 2025-01-23T11:05:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-da-banco-bpm-e-sace-200-milioni-di-euro-per-sostenere-la-crescita-nei-mercati-esteri/ 2025-01-23T13:35:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-innovative-medicine-75-di-autoanticorpi-in-meno-con-nipocalimab-nella-miastenia-grave-generalizzata/ 2025-01-23T15:46:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-ce-approva-combo-amivantamab-e-lazertinib-in-prima-linea-nel-nsclc-con-mutazioni-egfr/ 2025-01-24T11:05:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-biologics-la-cdmo-piu-performante-del-2024/ 2025-01-24T13:56:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-la-commissione-europea-firma-un-contratto-di-appalto-congiunto-per-i-vaccini-con-moderna-litalia-non-partecipa/ 2025-01-24T16:01:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-sara-brenner-commissario-ad-interim/ 2025-01-27T13:24:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-amicretina-nuovo-golden-bullet-per-lobesita/ 2025-01-27T14:02:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-scommette-sul-canada/ 2025-01-27T14:28:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-caso-emilia-romagna-confindustria-dm-lancia-nuovo-appello-alle-istituzioni/ 2025-01-27T16:26:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-italia-tavolo-di-lavoro-con-la-regione-campania-per-la-salute-cardiovascolare-dei-cittadini/ 2025-01-28T11:30:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-msd-aifa-approva-olaparib-in-combo-con-terapia-ormonale-in-prima-linea-nel-tumore-della-prostata/ 2025-01-28T14:14:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-polatuzumab-a-un-anno-dallapprovazione-italiana-nel-dlbcl-risparmio-e-sostenibilita-per-il-ssn/ 2025-01-28T15:22:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sage-therapeutics-respinge-lofferta-di-acquisto-di-biogen/ 2025-01-29T10:27:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-e-universita-di-oxford-collaborazione-per-scoprire-un-vaccino-contro-il-cancro/ 2025-01-29T11:14:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-pepaxti-oncopeptides-ottiene-la-rimborsabilita-in-italia/ 2025-01-29T17:06:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cda-aifa-nella-prima-seduta-dellanno-rimborsabilita-per-13-farmaci/ 2025-01-29T14:29:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-farmaceutici-tre-nuovi-amministratori-ned-nel-cda/ 2025-01-29T16:57:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-con-uninstallazione-a-roma-via-alla-campagna-per-cambiare-la-narrazione-dellobesita/ 2025-01-29T16:12:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/argenx-ok-aifa-a-rimborsabilita-efgartigimod-alfa-nella-mgg/ 2025-01-30T11:10:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-fda-approva-ozempic-per-i-pazienti-diabetici-con-ckd/ 2025-01-30T13:52:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-dimezzati-i-tempi-delle-procedure-di-ammissione-alla-rimborsabilita-dei-farmaci/ 2025-01-30T14:13:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-cda-aifa-ok-a-rimborsabilita-primo-radioligando-nel-carcinoma-prostatico/ 2025-01-30T15:21:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-julie-kim-nuova-ceo-dal-2026/ 2025-01-31T10:19:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-la-guidance-per-il-2025-vede-rosa/ 2025-01-31T16:19:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-forte-crescita-nel-2024-per-il-2025-vendite-in-aumento/ 2025-01-31T13:17:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-chmp-raccomanda-v116-per-la-vaccinazione-pneumococcica-degli-adulti/ 2025-02-03T16:03:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-aifa-ascolta-filo-diretto-tra-lagenzia-e-le-associazioni-dei-pazienti/ 2025-02-03T16:52:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-crescita-globale-di-oltre-il-10-la-filiale-italiana-prima-in-europa/ 2025-02-03T13:57:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vantive-segmento-di-baxter-kidney-care-diventa-societa-autonoma/ 2025-02-03T14:40:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-cancro-farmindustria-il-40-dei-farmaci-in-sviluppo-riguarda-larea-dei-tumori-nel-2010-era-pari-al-27/ 2025-02-03T14:52:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-approvata-anche-in-italia-estensione-di-hyqvia-come-terapia-di-mantenimento-nella-cipd/ 2025-02-03T15:43:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-un-viaggio-alla-scoperta-del-farmaco-in-occasione-del-world-cancer-day/ 2025-02-03T16:30:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bavarian-nordic-chmp-raccomanda-vaccino-chikungunya-per-adulti-e-adolescenti/ 2025-02-04T10:04:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-buyback-da-loreal-per-3-miliardi-di-euro/ 2025-02-04T10:50:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/influenza-ok-a-vaccino-sanofi-trivalente-ad-alto-dosaggio-per-gli-over-60/ 2025-02-04T15:29:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-seqirus-ok-ce-a-estensione-vaccino-antinfluenzale-su-coltura-cellulare-a-partire-dai-sei-mesi-di-eta/ 2025-02-05T13:33:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-presentato-a-roma-uno-studio-socio-economico-sulla-salute-mentale-in-italia/ 2025-02-04T15:27:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-nel-periodo-gennaiosettembre-2024-pari-a-176-mld-7-il-report-di-aifa/ 2025-02-04T15:05:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/una-fusione-strategica-per-ampliare-lofferta-terapeutica-lo-li-pharma-incorpora-farmares/ 2025-02-05T11:17:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-chmp-raccomanda-approvazione-durvalumab-come-monoterapia-nel-carcinoma-polmonare-a-piccole-cellule-in-stadio-limitato/ 2025-02-05T11:49:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-capitalizzazioni-di-mercato-aumentate-nel-2024-ma-non-mancano-le-ombre/ 2025-02-05T16:34:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mercato-dei-farmaci-2024-stabile-in-farmacia-nella-top-10-tachipirina-si-conferma-il-farmaco-piu-venduto-in-italia/ 2025-02-05T15:08:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-wegoy-superstar-del-2024-per-lanno-nuovo-vendite-in-crescita-tra-il-16-e-il-24/ 2025-02-06T17:20:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uk-la-mhra-lancia-una-consultazione-pubblica-per-le-linee-guida-delle-immunoterapie-oncologiche-a-mrna-personalizzate/ 2025-02-06T13:39:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-a-jeffrey-legos-la-gestione-del-portafoglio-oncologico/ 2025-02-07T11:38:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-q4-2024-mounjaro-e-zepbound-mettono-il-turbo-alle-vendite/ 2025-02-07T14:29:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ci-riprova-con-cagrisema-risultati-attesi-per-il-2026/ 2025-02-07T15:22:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/value-added-medicines-esiti-riportati-dai-pazienti-fondamentali-per-laccesso-al-mercato-ma-serve-rigore-metodologico/ 2025-02-10T17:57:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmacia-dei-servizi-cossolo-federfarma-in-due-anni-con-la-nuova-convenzione-sara-realta-in-ogni-parte-ditalia/ 2025-02-10T14:27:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-avvia-lo-studio-pivotale-del-farmaco-ror1-come-cura-di-prima-linea-del-linfoma/ 2025-02-10T18:11:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bain-capital-acquista-mitsubishi-tanabe-pharma-per-33-miliardi-di-dollari/ 2025-02-10T17:11:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tracciatura-farmaci-in-vigore-il-decreto-di-recepimento-delle-norme-ue-due-anni-di-adeguamento-per-nuovo-imballaggio/ 2025-02-10T18:10:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dialogo-politica-istituzioni-e-aziende-al-primo-ithaca-day/ 2025-02-10T17:27:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-al-via-la-vii-edizione-a-febbraio-il-festival-dellinnovazione-e-in-primavera-la-celebrazione-dei-best-of-2024/ 2025-02-10T19:01:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-abbvie-per-il-super-antibiotico-emblaveo-via-libera-anche-dalla-fda/ 2025-02-11T09:53:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hans-kluge-riconfermato-direttore-regionale-delloms-europa/ 2025-02-11T10:53:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sicurezza-informatica-healthcare-settore-piu-colpito-dagli-attacchi-hacker/ 2025-02-11T14:34:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-1-leadership-e-innovazione-etica-guidare-il-cambiamento-per-un-impatto-sociale-duraturo/ 2025-02-12T16:32:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-2-lintelligenza-artificiale-ridisegna-presente-e-futuro-della-sanita/ 2025-02-12T15:48:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-inaugura-impianto-di-vettori-virali-in-slovenia/ 2025-02-12T09:28:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-rafforza-la-pipleline-cardiovascolare-con-lacquisizione-di-anthos-therapeutics/ 2025-02-12T15:18:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-da-studio-checkmate-9er-conferma-efficacia-di-cabozantinib-associato-a-nivolumab-nel-carcinoma-a-cellule-renali-avanzato/ 2025-02-12T16:48:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regno-unito-da-governo-82-mln-di-sterline-per-lai-nella-ricerca-dei-farmaci/ 2025-02-12T13:48:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-3-il-digitale-che-trasforma-e-innova-lesperienza-del-paziente/ 2025-02-13T09:20:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-accordo-con-royalty-pharma-per-sviluppare-candidato-per-il-lupus/ 2025-02-13T09:51:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-la-commissione-europea-approva-acoramidis-nel-trattamento-dellattr-cm/ 2025-02-13T10:47:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-4-guidare-il-futuro-la-sfida-della-leadership-nellera-della-digital-transformation/ 2025-02-14T14:52:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-nel-periodo-gennaio-ottobre-2024-sale-del-75-a-196-miliardi-di-euro-il-report-aifa/ 2025-02-13T11:54:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-5-cure-migliori-e-sistemi-sanitari-piu-sostenibili-grazie-ai-dati/ 2025-02-13T16:54:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-arriva-in-italia-spesolimab-per-la-psoriasi-pustolosa-generalizzata/ 2025-02-13T14:00:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-salute-mentale-dieci-proposte-per-la-regione-campania/ 2025-02-13T15:39:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-6-verso-una-sanita-piu-sostenibile-e-non-solo-economicamente/ 2025-02-14T08:24:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-show-7-sostenibilita-e-innovazione-la-nuova-alleanza-per-il-successo-nel-xxi-secolo/ 2025-02-14T08:51:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-luiss-business-school-lintegrazione-dei-rifugiati-nel-mondo-del-lavoro-come-scelta-strategica-e-opportunita-concreta/ 2025-02-14T10:46:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obesita-un-mercato-che-cresce-del-32-allanno/ 2025-02-14T15:14:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-con-progetto-interceptor-passo-avanti-verso-terapie-target-per-lalzheimer/ 2025-02-17T14:54:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/polifarma-acquisisce-hennig-arzneimittel/ 2025-02-17T15:13:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-via-libera-dalla-ce-a-garadacimab-nellangioedema-ereditario-negli-over-12/ 2025-02-17T11:19:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/galderma-approvazione-europea-per-nemolizumab-nella-dermatite-atopica-e-nella-prurigo-nodularis/ 2025-02-17T12:00:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-marchio-ce-per-due-nuovi-device-per-lablazione-cardiaca/ 2025-02-17T14:09:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-brusca-frenata-nel-2024/ 2025-02-18T10:23:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/meta-azienda-e-donna-novartis-italia-ottiene-la-certificazione-per-la-parita-di-genere/ 2025-02-18T11:29:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-firmato-protocollo-dintesa-con-autorita-per-i-medicinali-di-malta/ 2025-02-18T13:46:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-a-milano-e-padova-si-sperimenta-la-stimolazione-cerebrale-adattativa-nel-parkinson/ 2025-02-18T16:36:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zentiva-sostiene-la-campagna-nazionale-di-sensibilizzazione-per-un-cuore-sano-conta-ogni-centimetro/ 2025-02-19T14:37:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-hiv-fda-accetta-nda-per-lenacapavir-come-prep-la-decisione-a-giugno/ 2025-02-19T10:55:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-da-aprile-dazi-del-25-sulla-farmaceutica/ 2025-02-19T11:33:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmacistapiu-farmacisti-a-confronto-sullevoluzione-del-ssn-tra-innovazione-e-prossimita-delle-cure/ 2025-02-19T17:16:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-con-aflibercept-8-mg-e-il-dispositivo-ocuclick-un-passo-avanti-nella-gestione-delle-maculopatie/ 2025-02-19T14:18:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-75-mln-di-dollari-per-un-progetto-di-awareness-in-usa-sul-cancro-alla-prostata/ 2025-02-20T11:04:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-ok-ce-a-seladelpar-nella-colangite-biliare-primitiva/ 2025-02-20T11:48:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-lancia-ai-coscientist/ 2025-02-20T14:51:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-fda-concede-la-revisione-prioritaria-per-lnda-di-zongertinib-nel-nsclc/ 2025-02-21T10:45:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ce-approva-belzutifan-per-rcc-e-malattia-di-von-hippel-lindau/ 2025-02-21T13:43:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-acquisisce-la-filiale-cinese-di-fibrogen/ 2025-02-21T14:24:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servono-alternative-al-payback-aziende-verso-nuovo-ricorso-a-tar-ma-superarlo-si-puo-intervista-a-confalone-novartis/ 2025-02-24T08:23:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bluebird-bio-acquisita-da-due-societa-di-private-equity/ 2025-02-24T10:35:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-nuovi-risultati-per-guselkumab-nella-colite-ulcerosa/ 2025-02-24T16:49:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-appello-di-sette-associazioni-il-tar-del-lazio-lo-dichiari-illegittimo/ 2025-02-25T09:11:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-hiv-anche-lema-valuta-lenacapavir-come-prep/ 2025-02-25T09:45:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-nomina-come-nuovo-cmo-patrizia-cavazzoni-ex-alto-funzionario-della-fda/ 2025-02-25T10:16:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celltrion-ok-ce-a-biosimilare-di-tocilizumab/ 2025-02-25T11:17:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-dellovaio-ovarian-cancer-commitment-chiede-accesso-omogeneo-e-rimborsabilita-per-il-test-hrd/ 2025-02-25T15:47:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fuoco-di-santantonio-un-italiano-su-2-non-conosce-la-pericolosita-dellherpes-zoster-e-soprattutto-fra-i-50-ed-i-60-anni-ne-sottovaluta-i-rischi/ 2025-02-25T16:18:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/thermo-fisher-acquisisce-la-unit-di-purificazione-di-solventum-per-4-mld-di-dollari/ 2025-02-26T16:03:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/indicazioni-dei-farmaci-oncologici-differenze-nel-52-dei-casi-fra-ema-e-fda/ 2025-02-26T10:09:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zambon-sceglie-massimo-grandi-come-chief-core-therapies-officer/ 2025-02-26T10:41:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-msd-da-milano-riparte-la-campagna-tumori-eredo-familiari-conoscerli-e-il-primo-passo/ 2025-02-26T12:04:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-arriva-la-campagna-chiamalepernome-per-sensibilizzare-sulle-malattie-rare/ 2025-02-26T14:59:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antimicrobico-resistenza-lesperienza-del-lazio-contro-una-delle-piu-grandi-emergenze-sanitarie-dei-nostri-tempi/ 2025-02-26T15:46:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-accordo-con-bridgene-per-sviluppare-small-molecule-in-neurologia-e-immunologia/ 2025-02-27T13:17:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-50-miliardi-di-dollari-per-ricollocare-la-produzione-negli-usa/ 2025-02-27T11:09:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-dellobesita-novo-nordisk-lancia-il-portale-novo-io/ 2025-02-27T13:16:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/indivior-joe-ciaffoni-e-il-nuovo-ceo/ 2025-02-28T10:09:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/report-patientview-2024-cresce-linteresse-per-i-temi-esg-per-gilead-un-primo-e-un-secondo-posto/ 2025-02-28T15:39:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-paolo-foggi-confermato-chair-dello-scientific-advice-working-party/ 2025-02-28T15:26:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-chmp-a-iptacopan-nella-glomerulopatia-da-c3/ 2025-03-03T09:30:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-eisai-chmp-dellema-conferma-raccomandazione-per-lecanemab-nella-terapia-dellalzheimer/ 2025-03-03T11:25:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-da-aifa-rimborsabilita-per-ftdtpi-piu-bevacizumab-nel-carcinoma-colorettale-metastatico/ 2025-03-03T11:56:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-parte-ledizione-2025-dei-bandi-dedicati-alla-ricerca-scientifica-italiana-e-alle-associazioni-di-pazienti/ 2025-03-03T14:11:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/protocollo-dintesa-tra-agenas-e-assosoftware-per-potenziamento-digitalizzazione-del-ssn/ 2025-03-03T14:47:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-entra-nel-settore-dellobesita-accordo-con-gubra-da-23-miliardi-di-dollari/ 2025-03-04T09:28:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-rsv-parere-positivo-chmp-per-vaccino-abrysvo-negli-adulti-tra-i-18-e-i-59-anni/ 2025-03-04T09:56:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ozgur-yaziyurt-e-il-nuovo-country-president-di-pfizer-in-italia/ 2025-03-04T11:07:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotici-non-si-ferma-laumento-dei-consumi-6-nel-2023-nistico-fenomeno-batteri-resistenti-costa-24-mld-di-euro-al-ssn/ 2025-03-04T11:59:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-approva-la-rimborsabilita-di-risdiplam-per-neonati-con-sma-fin-dai-primi-giorni-di-vita/ 2025-03-04T14:21:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-ce-approva-mirikizumab-per-il-trattamento-della-malattia-di-crohn-in-fase-attiva-da-moderata-a-grave-nei-pazienti-adulti/ 2025-03-04T15:42:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-in-gu-rimborsabilita-ssn-per-il-primo-radioligando-nel-carcinoma-prostatico-resistente-alla-castrazione/ 2025-03-05T10:21:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cresce-il-gruppo-menarini-46-mld-di-fatturato-2024-52-ebitda-a-460-mln-di-euro/ 2025-03-05T16:35:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/telemedicina-il-73-dei-professionisti-sanitari-italiani-vorrebbe-integrarla-nella-pratica-clinica/ 2025-03-05T14:05:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-astrazeneca-rare-disease-da-aifa-ok-a-rimborsabilita-asfotase-alfa-nella-hpp-a-esordio-pediatrico/ 2025-03-05T14:30:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-chmp-raccomanda-durvalumab-piu-chemioterapia-per-nsclc-resecabile/ 2025-03-05T15:40:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-parere-positivo-chmp-per-upadacitinib-nellarterite-a-cellule-giganti/ 2025-03-06T10:12:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jazz-pharmaceuticals-acqusisce-chimerix-operazione-da-935-milioni-di-dollari/ 2025-03-06T10:52:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-bene-il-primo-anno-da-azienda-autonoma/ 2025-03-06T11:23:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ssn-nasce-lecosistema-dei-dati-sanitari/ 2025-03-06T13:50:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-ema-pubblica-bando-di-gara-per-progetti-di-ricerca-su-qualita-sicurezza-ed-efficacia/ 2025-03-07T09:29:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-punta-allacquisizione-di-springworks-therapeutics/ 2025-03-07T16:37:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-le-donne-verso-un-cuore-consapevole-focus-a-milano-sulle-malattie-cardiovascolari-femminili-e-medicina-di-genere/ 2025-03-07T16:17:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/direttiva-europea-acque-reflue-urbane-le-aziende-dei-farmaci-off-patent-la-impugnano-davanti-alla-corte-di-giustizia-ue/ 2025-03-10T15:49:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-e-yaskawa-electric-corporation-nasce-la-joint-venture-giapponese-per-le-terapie-cellulari/ 2025-03-10T13:41:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ok-ce-a-combo-nivolumabipilimumab-come-terapia-di-prima-linea-nellhcc/ 2025-03-11T09:38:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-negli-usa-un-hub-per-le-patologie-cvrm/ 2025-03-11T09:42:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-con-tezepelumab-nuove-prospettive-di-trattamento-per-la-rinosinusite-cronica-con-poliposi-nasale/ 2025-03-11T10:46:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lefpia-ricorre-alla-corte-ue-contro-direttiva-europea-su-acque-reflue/ 2025-03-11T14:24:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharma-acquisisce-checkpoint-therapeutics/ 2025-03-11T14:22:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-nuovo-impianto-di-produzione-da-1-miliardo-di-dollari-per-il-vaccino-gardasil/ 2025-03-12T09:32:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-per-contrastare-le-carenze-nella-ue-supporto-alla-produzione-e-incentivi-per-le-aziende-arriva-il-critical-medicines-act/ 2025-03-12T09:56:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-acquisisce-spin-off-di-bluebird-bio/ 2025-03-12T10:31:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-dupilumab-efficace-nel-trattamento-del-pemfigoide-bolloso-i-dati-dello-studio-registrativo-adept/ 2025-03-12T18:05:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digitalizzazione-nasce-il-forum-nazionale-salute-digitale-per-una-sanita-al-passo-con-i-tempi/ 2025-03-12T12:48:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-europe-la-fibrillazione-atriale-si-combatte-anche-a-tavola-evento-a-milano-con-lo-chef-ruben-bondi/ 2025-03-12T13:54:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-sacituzumab-govitecan-esteso-alle-donne-con-carcinoma-mammario-metastatico-hrher2/ 2025-03-12T15:56:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-consultazione-pubblica-sui-criteri-di-attribuzione-dellinnovativita-terapeutica-per-laccesso-al-fondo-dei-farmaci-innovativi/ 2025-03-12T16:07:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-zealand-pharma-partnership-miliardaria-per-trattare-lobesita/ 2025-03-13T09:32:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-del-seno-rapporto-economist-impact-bene-litalia-per-accesso-e-rimborsabilita-delle-cure-ma-prevenzione-e-screening-ancora-sotto-la-soglia-minima-raccomandata-in-ue/ 2025-03-13T13:50:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/distribuzione-da-ospedali-a-farmacie-gemmato-si-prosegue-con-medicinali-simili-fra-obiettivi-anche-farmaci-orfani/ 2025-03-13T13:55:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-dispositivi-medici-istituito-tavolo-tecnico-al-mef-presieduto-da-giorgetti-primo-incontro-il-21-marzo/ 2025-03-14T15:24:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-rui-santos-ivo-nuovo-presidente-del-consiglio-di-amministrazione/ 2025-03-14T09:45:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-hiv-nuovi-dati-importanti-su-lenacapavir-come-prep-annuale-presto-lo-studio-di-fase-iii/ 2025-03-14T11:27:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mallinckrodt-ed-endo-merger-da-67-miliardi-di-dollari/ 2025-03-14T14:47:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-farmaceutico-quali-priorita-per-il-futuro-partecipa-al-sondaggio/ 2025-03-17T09:29:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-studio-mirasol-mirvetuximab-soravtansine-riduce-di-un-terzo-il-rischio-di-morte-nel-cancro-ovarico/ 2025-03-17T10:37:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-antipneumococco-pcv20-uno-studio-hta-lo-promuove-come-nuova-arma-contro-le-infezioni-pneumococciche-nei-bambini/ 2025-03-17T14:05:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-edison-aziende-farmaceutiche-a-capitale-italiano-motore-delleconomia-del-paese/ 2025-03-17T13:59:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-acquisisce-la-belga-esobiotech-per-rafforzarsi-nelle-terapie-cellulari/ 2025-03-18T10:08:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-commissione-europea-approva-lisocel-nel-trattamento-del-linfoma-follicolare/ 2025-03-18T10:43:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-pubblica-strategia-congiunta-con-agenzie-di-regolamentazione-dei-medicinali-dellue-fino-al-2028/ 2025-03-18T16:41:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/telemedicina-per-le-apnee-notturne-uno-studio-italiano-ne-dimostra-lefficacia/ 2025-03-18T17:31:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shionogi-ensitrelvir-funziona-come-profilassi-post-esposizione-al-covid-19/ 2025-03-18T18:21:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-da-oggi-al-2050-il-cancro-costera-alleconomia-globale-piu-di-25-trilioni-di-dollari/ 2025-03-19T09:42:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-accordo-con-alteogen-per-formulazioni-sottocutanee-di-terapie-oncologiche/ 2025-03-19T14:29:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pierre-fabre-da-aifa-rimborsabilita-per-tabelecleucel-nel-trattamento-della-ptld-positiva-al-virus-epstein-barr/ 2025-03-19T14:40:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-e-lundbeck-ce-approva-brexpiprazolo-per-il-trattamento-della-schizofrenia-negli-adolescenti-over-13/ 2025-03-19T13:40:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-online-il-nuovo-regolamento-per-la-prevenzione-e-gestione-dei-conflitti-di-interesse/ 2025-03-19T14:18:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-partnership-con-oxford-biotherapeutics-per-terapie-oncologiche-basate-su-anticorpi/ 2025-03-20T10:09:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intelligenza-artificiale-ema-qualifica-il-primo-strumento-per-diagnosticare-la-malattia-infiammatoria-epatica/ 2025-03-20T13:06:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/google-arrivano-nuovi-modelli-ai-open-source-per-la-ricerca-farmacologica/ 2025-03-20T14:15:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/attenzione-ai-dazi-usa-istat-italia-forte-in-export-farmaci-ma-il-23-delle-operazioni-e-vulnerabile-a-trend-mercato-estero/ 2025-03-20T14:17:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-accordo-da-19-mld-di-dollari-per-un-anticorpo-di-dren-bio/ 2025-03-21T13:24:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-cede-partecipazione-residua-in-haleon/ 2025-03-21T13:24:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-e-lundbeck-da-aifa-ok-rimborsabilita-aripiprazolo-iniettabile-a-lunga-durata-dazione-nel-mantenimento-di-pazienti-adulti-con-schizofrenia/ 2025-03-21T10:50:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-dm-filiera-industriale-confronto-costruttivo-con-governo/ 2025-03-21T13:15:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-25-miliardi-di-dollari-per-un-centro-ricerca-e-sviluppo-in-cina/ 2025-03-24T10:55:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/commissione-aifa-approva-passaggio-delle-gliflozine-a-distribuzione-in-farmacia/ 2025-03-25T09:04:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-cinema-e-in-tv-resiste-lo-stigma-sulle-malattie-i-risultati-di-una-ricerca-usa-sponsorizzata-eli-lilly/ 2025-03-24T13:46:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ia-un-futuro-o-presente-anche-nel-naming-farmaceutico/ 2025-03-24T15:22:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-potenzia-la-produzione-statunitense-mentre-le-big-pharma-si-riforniscono-di-nuovi-impianti/ 2025-03-25T09:11:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-nominera-la-direttrice-ad-interim-del-cdc-susan-monarez-alla-guida-permanente-dellautorita/ 2025-03-25T09:11:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/flavia-binetti-e-il-nuovo-amministratore-delegato-di-organon-italia/ 2025-03-25T10:01:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-accordo-con-biotech-cinese-da-200-mln-di-dollari-per-arricchire-la-pipeline-di-farmaci-per-lobesita/ 2025-03-25T10:38:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/competitivita-dellindustria-farmaceutica-europea-la-ricetta-dellefpia/ 2025-03-26T10:23:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-accordo-con-jiangsu-hengrui-pharmaceuticals-su-candidato-cv-che-mira-alla-lipoproteina-a/ 2025-03-26T09:51:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-revisione-prioritaria-fda-per-tolebrutinib-nella-sm/ 2025-03-26T13:27:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/makary-confermato-al-vertice-della-fda-ecco-le-sfide-che-lo-attendono/ 2025-03-27T09:17:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-fda-approva-gepotidacina-primo-antibiotico-per-le-uti-dopo-30-anni/ 2025-03-27T10:00:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-fast-track-fda-a-vaccino-mrna-per-linfezione-da-clamidia/ 2025-03-27T10:24:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-pfizer-il-premio-minerva-2025/ 2025-03-27T13:31:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-farmaceutico-del-futuro-focus-su-dati-omnicanalita-e-contenuti-innovativi/ 2025-03-27T14:09:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-aifa-approva-nivolumab-nelle-fasi-precoci-di-melanoma-e-carcinoma-polmonare/ 2025-03-27T14:47:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-nuovo-sito-produttivo-a-nerviano/ 2025-03-28T08:45:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-crescita-record-nel-2024/ 2025-03-28T09:23:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-incontro-a-milano-per-fare-il-punto-sul-ruolo-della-lpa-nel-rischio-cardiovascolare/ 2025-03-28T10:25:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-nuovo-accordo-miliardario-per-ampliare-la-pipeline-dellobesita/ 2025-03-31T08:34:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-si-dimette-peter-marks-responsabile-dellufficio-che-si-occupa-dei-vaccini/ 2025-03-31T09:44:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-nello-studio-score-semaglutide-riduce-gli-eventi-cardiovascolari-nei-pazienti-con-obesita-e-malattia-cardiaca/ 2025-03-31T10:47:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-una-campagna-di-sensibilizzazione-sulle-infezioni-respiratorie-per-un-giubileo-2025-in-sicurezza/ 2025-03-31T14:28:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fatigue-nellepn-un-sintomo-cruciale-sottovalutato-i-dati-della-ricerca-iqvia-in-collaborazione-con-novartis/ 2025-03-31T13:31:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/becton-dickinson-matteo-danielli-e-il-nuovo-gm-italia-e-grecia/ 2025-04-01T09:17:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-aggiorna-tariffe-prestazioni-sulla-base-dellindice-istat/ 2025-04-01T12:33:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotici-in-veterinaria-in-italia-aumenta-consumo-ma-rimane-sotto-media-ue/ 2025-04-01T12:39:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-ottimi-risultati-per-lepodisiran-candidato-cv-che-mira-alla-lipoproteina-a/ 2025-04-01T12:46:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-via-libera-fda-a-fitusiran-nellemofilia-a-e-b/ 2025-04-01T13:29:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2024-anno-boom-per-i-blockbuster-asset/ 2025-04-01T14:48:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cattani-guerra-dei-dazi-declino-della-competitivita-ue-instabilita-delle-filiere-produttive-quadro-molto-complesso-e-incerto-occorre-passare-allazione/ 2025-04-02T08:42:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ce-estende-vaccino-rsv-agli-adulti-tra-i-18-e-i-59-anni/ 2025-04-02T16:35:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bavarian-nordic-da-fda-via-libera-versione-liofilizzata-del-vaccino-smallpox-e-mpox/ 2025-04-02T09:53:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sperimentazione-farmacia-dei-servizi-in-stato-regioni-la-proposta-di-riparto-di-253-milioni-per-il-2025/ 2025-04-02T14:19:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/organon-acquisisce-da-biogen-i-diritti-usa-su-tofidence-biosimilare-di-tocilizumab/ 2025-04-03T07:42:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibsa-festeggia-40-anni-di-storia/ 2025-04-03T07:58:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-cda-aifa-approva-la-rimborsabilita-di-10-farmaci/ 2025-04-03T10:15:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dazi-collatina-egualia-gli-usa-importano-il-70-dei-principi-attivi-e-per-700-molecole-leuropa-e-lunico-fornitore/ 2025-04-03T10:20:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicina-di-prossimita-e-cura-digitale-studio-prosafe-cambiamento-positivo-per-l85-dei-pazienti-ma-il-60-teme-insufficiente-supporto-nel-percorso-di-assistenza/ 2025-04-03T11:49:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/via-libera-ue-a-iptacopan-di-novartis-per-i-pazienti-adulti-con-glomerulopatia-da-c3/ 2025-04-03T14:16:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-dallalleanza-per-uninfanzia-libera-da-rsv-il-documento-di-indirizzo-per-la-stagione-20252026/ 2025-04-07T10:36:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-e-iniziata-lera-dei-dazi-quanto-costera-al-mondo-pharma/ 2025-04-04T09:53:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuovi-risultati-positivi-per-onasemnogene-abeparvovec-intratecale-nella-sma/ 2025-04-04T11:00:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ai-isomorphic-labs-sostenuta-da-google-raccoglie-600-mln-di-dollari-per-programmi-di-scoperta-farmaci/ 2025-04-04T14:50:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-nei-primi-11-mesi-del-2024-supera-i-215-miliardi-di-euro/ 2025-04-04T14:47:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ma-big-pharma-sotto-la-quota-del-miliardo-di-dollari-nei-primi-tre-mesi-dellanno/ 2025-04-07T10:01:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-aifa-disponibile-online-osmed-interattivo-laggiornamento-sui-consumi-e-la-spesa-farmaceutica-in-italia/ 2025-04-07T12:09:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-alla-design-week-con-zeus-il-cavallo-icona-delle-olimpiadi-di-parigi-2024/ 2025-04-07T13:03:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-protocollo-dintesa-con-garante-salute-regione-calabria-per-migliorare-lassistenza-ai-cittadini/ 2025-04-07T14:18:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-accordo-con-biotech-sudcoreana-nel-campo-delle-malattie-neurodegenerative/ 2025-04-08T14:19:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-medicare-non-copre-piu-i-farmaci-anti-obesita-allarme-per-eli-lilly-e-novo-nordisk/ 2025-04-09T06:31:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-da-aifa-chiarimenti-sullapplicazione-della-maggiorazione-della-quota-spettante-ai-grossisti/ 2025-04-08T12:14:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-diagnostics-la-citta-della-salute-e-della-scienza-di-torino-adotta-prima-in-italia-la-nuova-tecnologia-della-spettrometria-di-massa/ 2025-04-08T14:07:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/appello-dei-ceo-europei-a-von-der-leyen-senza-un-cambio-di-politica-rischio-esodo-delle-industrie-verso-gli-stati-uniti/ 2025-04-09T15:26:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-da-ce-ok-a-estensione-daratumumab-sottocutaneo-nel-trattamento-di-prima-linea-del-ndmm/ 2025-04-09T09:14:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-da-fda-designazione-di-farmaco-orfano-a-tilzabrutinib-per-due-malattie-rare-prive-di-trattamenti-approvati/ 2025-04-09T10:14:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/le-aziende-sanitarie-territoriali-ospedaliero-univesitarie-e-irccs-di-bologna-e-firenze-verso-la-neutralita-climatica-entro-il-2030/ 2025-04-09T10:43:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-vs-cina-chi-vincera-la-sfida-del-biotech/ 2025-04-09T13:46:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-il-farmaco-sperimentale-azd0780-riduce-significativamente-il-colesterolo-ldl-levidenza-dallo-studio-pursuit/ 2025-04-10T09:02:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-tolebrutinib-ritarda-la-progressione-della-disabilita-nelle-persone-con-nrspms/ 2025-04-10T10:34:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-ce-a-upadacitinib-nellarterite-a-cellule-giganti/ 2025-04-10T12:44:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-italiano-un-settore-trainante-che-stimolera-la-domanda-di-lavoro-nei-prossimi-dieci-anni/ 2025-04-10T15:49:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-vaccinazione-contro-il-virus-respiratorio-sinciziale-rsv-limpatto-sullospedalizzazione-degli-anziani-in-scozia/ 2025-04-10T15:15:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-in-italia-fabrizio-colajanni-e-il-nuovo-finance-administration-director/ 2025-04-11T08:00:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-leucemia-mieloide-cronica-la-parola-ai-pazienti/ 2025-04-11T09:23:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kyowa-kirin-sceglie-martino-villa-come-southern-cluster-hr-director-per-spagna-italia-e-portogallo/ 2025-04-11T10:08:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-stanzia-23-mld-di-dollari-per-potenziare-la-produzione-usa/ 2025-04-11T10:54:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmacie-dallanalisi-dei-bisogni-del-territorio-alla-formazione-in-unindagine-homnya-tutti-i-segreti-del-successo-della-performance/ 2025-04-11T14:40:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mastoplastica-additiva-un-consensus-di-esperti-a-milano-per-la-bellezza-naturale-del-seno/ 2025-04-11T13:15:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-cda-approva-il-bando-di-ricerca-indipendente-per-il-2025-sulle-malattie-rare/ 2025-04-11T13:33:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-con-ai-e-nuovi-modelli-di-laboratorio-stop-ai-test-sugli-animali/ 2025-04-14T14:21:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aiom-al-via-campagna-di-sensibilizzazione-alle-vaccinazioni-rivolta-ai-pazienti-oncologici-con-il-contributo-non-condizionante-di-gsk/ 2025-04-14T10:00:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ce-approva-v116-per-la-vaccinazione-pneumococcica-degli-adulti/ 2025-04-14T10:54:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/philips-record-di-brevetti-in-europa-nellhealth-technology/ 2025-04-14T12:38:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-innovative-medicine-talquetamab-rimborsato-in-italia-nel-mm/ 2025-04-14T14:26:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/export-farmaceutico-europeo-eurostat-135-nel-2024-a-quota-3134-mld-di-euro/ 2025-04-14T13:56:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-ce-a-glofitamab-in-combinazione-con-gemox-nel-dlbcl/ 2025-04-15T08:27:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-nuova-approvazione-fda-per-nivolumab-ipilumab/ 2025-04-15T10:04:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stati-uniti-avviate-indagini-sulle-importazioni-di-prodotti-farmaceutici-e-chip/ 2025-04-15T09:31:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-disco-verde-ce-per-pirtobrutinib-nella-cll-precedentemente-trattata-con-inibitore-btk/ 2025-04-15T10:03:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dazi-sui-farmaci-rischio-aumento-prezzi-carenze-e-stop-investimenti-in-europa-laifa-al-lavoro-per-approvare-113-nuovi-farmaci-dopo-via-libera-ema-intervista-a-robert-nistico/ 2025-04-15T12:19:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/globaldata-con-i-dazi-cresce-il-rischio-di-una-recessione-globale/ 2025-04-16T08:23:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-raggiunto-laccordo-su-una-bozza-di-trattato-pandemico-globale/ 2025-04-16T08:48:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-crescita-a-doppia-cifra-nel-2024/ 2025-04-16T09:52:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-seqirus-approvato-dalla-commissione-europea-il-vaccino-trivalente-prodotto-su-coltura-cellulare-con-indicazione-a-partire-dai-6-mesi-di-eta/ 2025-04-16T10:10:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ccnl-dei-settori-chimico-e-farmaceutico-ipotesi-di-accordo-per-il-periodo-20252028-rinnovato-con-anticipo-rispetto-alla-scadenza/ 2025-04-16T10:22:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-ordine-esecutivo-di-trump-per-ridurli-e-mettere-gli-americani-al-primo-posto-misure-per-per-anziani-iscritti-a-medicare-e-insulina/ 2025-04-16T13:07:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-summit-fermare-lepidemia-e-ancora-possibile/ 2025-04-16T14:05:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-nominati-i-componenti-esterni-del-comitato-valutazione-dei-conflitti-dinteressi/ 2025-04-16T14:03:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-biogen-la-ce-autorizza-limmissione-in-commercio-di-lecanemab/ 2025-04-17T13:46:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/report-horizon-scanning-aifa-in-arrivo-vaccini-cure-per-tumori-e-alzheimer/ 2025-04-17T09:11:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-non-teme-i-dazi-e-aumenta-le-stime-di-vendita-bene-il-q1-2025/ 2025-04-17T10:09:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/radiofarmaci-ecco-le-nuove-raccomandazioni-europee/ 2025-04-17T13:32:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/in-italia-120-000-persone-colpite-da-alopecia-areata-approvato-il-primo-trattamento-orale/ 2025-04-17T15:15:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-dm-giorgetti-e-come-un-cerotto-su-unemorragia-plaudono-le-associazioni-di-categoria/ 2025-04-17T17:26:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-e-cue-biopharma-accordo-per-sviluppare-candidato-contro-patologie-autoimmuni/ 2025-04-18T08:48:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-approva-la-prima-terapia-digitale-per-lemicrania-episodica/ 2025-04-18T09:20:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-da-startup-usa-due-candidati-per-patologie-autoimmuni-e-infiammatorie/ 2025-04-18T09:45:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intervista-a-pierluigi-russo-aifa-su-norma-de-listing-preconcetti-monitoraggio-costi-in-corso/ 2025-04-18T10:08:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/strategia-europea-per-le-life-sciences-efpia-rafforzare-produzione-farmaceutica-e-impegno-in-sperimentazioni-cliniche/ 2025-04-18T12:19:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-dallo-studio-achieve1-ottimi-risultati-per-orforglipron-nella-perdita-di-peso/ 2025-04-18T13:33:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-regeneron-fda-approva-dupilumab-nellorticaria-cronica-spontanea/ 2025-04-22T08:28:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ha-presentato-domanda-alla-fda-per-semglutide-orale-nel-trattamento-dellobesita/ 2025-04-22T15:21:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dazi-anche-le-pharma-europee-iniziano-a-investire-in-usa-e-la-volta-di-roche/ 2025-04-22T10:23:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-accordo-di-ricerca-con-biotech-usa-per-terapie-anticorpali/ 2025-04-22T13:21:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ma-leuropa-si-muove-kkr-verso-lacquisizione-della-svedese-biotage-per-12-mld-di-dollari/ 2025-04-23T09:14:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-buoni-risultati-preliminari-da-studio-real-world-su-vaccino-covid-adattato-a-variante-jn1/ 2025-04-23T12:21:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ceo-novartis-e-sanofi-contro-dazi-usa-alzare-i-prezzi-in-europa-o-le-aziende-batteranno-la-ritirata/ 2025-04-23T09:55:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/galapagos-henry-gosebruch-guidera-la-spinout-dedicata-alla-ricerca/ 2025-04-23T10:29:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incontro-a-londra-vertici-aifamhra-nistico-gettiamo-le-basi-per-una-maggior-collaborazione-sulla-ricerca-clinica-laccesso-allinnovazione-e-la-sicurezza-dei-farmaci/ 2025-04-23T14:38:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-grande-q1-e-guidance-2025-confermata/ 2025-04-24T15:39:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-partnership-con-tessellate-bio-per-sviluppare-terapie-contro-i-tumori-alt/ 2025-04-24T15:41:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-marchio-ce-per-algoritmo-che-analizza-il-dolore-toracico/ 2025-04-24T12:55:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/united-states-pharmacopeia-i-dazi-colpiranno-i-produttori-di-farmaci-generici/ 2025-04-24T13:45:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/reshoring-in-usa-e-il-momento-di-abbvie/ 2025-04-28T08:44:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-altri-900-mln-di-dollari-per-lo-stabilimento-produttivo-in-ohio/ 2025-04-28T09:09:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-partnership-a-tre-per-sviluppare-farmaci-con-lai/ 2025-04-28T09:58:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-q1-trainato-dai-farmaci-per-lhiv/ 2025-04-28T10:46:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-chmp-raccomanda-16-nuovi-farmaci-inclusa-terapia-per-duchenne/ 2025-04-28T11:47:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/resistenza-agli-antibiotici-efpia-tev-meno-costosi-del-45-rispetto-a-stime-ue/ 2025-04-29T07:42:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-conclude-un-accordo-da-39-miliardi-di-dollari-per-springworks/ 2025-04-29T07:50:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tremfya-di-jj-ottiene-lautorizzazione-allimmissione-in-commercio-nella-ce-come-terapia-della-colite-ulcerosa/ 2025-04-29T07:51:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-ottiene-lapprovazione-dellue-per-lanticorpo-bispecifico-lynozyfic-e-prepara-lo-scontro-con-jj-e-pfizer/ 2025-04-29T07:52:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-il-consiglio-di-amministrazione-apre-al-rinnovo-del-mandato-a-emer-cooke/ 2025-04-29T08:20:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-presidente-della-repubblica-farmaceutica-punto-di-forza-per-litalia/ 2025-04-29T10:37:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rare-diseases-chiesi-italia-lancia-mylipids-app-per-supportare-le-persone-affette-da-hofh-e-ipercolesterolemia-familiare/ 2025-04-29T14:38:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-avanza-la-pipeline-dellarea-respiratoria/ 2025-04-30T09:26:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-la-corsa-non-si-ferma-aifa-trend-in-linea-con-gli-anni-precedenti/ 2025-04-30T10:29:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-al-via-i-lavori-per-un-nuovo-stabilimento-produttivo-negli-usa-da-un-miliardo-di-dollari/ 2025-04-30T12:39:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-q1-in-calo-ma-previsioni-finanziare-confermate-per-il-2025/ 2025-04-30T16:52:47+00:00 monthly 0.2